Edgar Filing: Kraton Performance Polymers, Inc.

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q



ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-34581

KRATON PERFORMANCE POLYMERS, INC.

(Exact Name of Registrant as Specified in its Charter)



Delaware	20-0411521
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

15710 John F. Kennedy Blvd. Suite 300 Houston, TX 77032	281-504-4700
(Address of principal executive offices, including zip code)	(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act. (Check one):



Large accelerated filer:	ý	Accelerated filer:	¨
Non-accelerated filer:	¨	Smaller reporting company:	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No ý

Number of shares of Kraton Performance Polymers, Inc. Common Stock, $0.01 par value, outstanding as of October 26, 2015: 30,523,598.

Index to Quarterly Report

on Form 10-Q for

Quarter Ended September 30, 2015



PART I. FINANCIAL INFORMATION		Page

	The Report of KPMG LLP, Independent Registered Public Accounting Firm	5

Item 1	Condensed Consolidated Financial Statements (Unaudited)	6

	Condensed Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014	6

	Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2015 and 2014	7

	Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2015 and 2014	8

	Condensed Consolidated Statements of Changes in Equity for the nine months ended September 30, 2015 and 2014	9

	Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2015 and 2014	10

	Notes to the Condensed Consolidated Financial Statements	11

Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	38

Item 3	Quantitative and Qualitative Disclosures About Market Risk	52

Item 4	Controls and Procedures	52

PART II. OTHER INFORMATION

Item 1	Legal Proceedings	53

Item 1A	Risk Factors	53

Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	54

Item 6	Exhibits	55

	Signatures	56

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Some of the statements in this Quarterly Report on Form 10-Q under the headings “Condensed Consolidated Financial Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We may also make written or oral forward-looking statements in our periodic reports on Forms 10-K, 10-Q and 8-K, in press releases and other written materials and in oral statements made by our officers, directors or employees to third parties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “outlook,” “believes,” “estimates,” “expects,” “projects,” “may,” “intends,” “plans” or “anticipates,” or by discussions of strategy, plans or intentions; anticipated benefits of or performance of our products; beliefs regarding opportunities for new, differentiated applications and other innovations; adequacy of cash flows to fund our working capital requirements; our investment in the joint venture with Formosa Petrochemical Corporation (“FPCC”); our expectations regarding indebtedness to be incurred by our joint venture with FPCC; our anticipated close of the pending acquisition of Arizona Chemical Holdings Corporation (“Arizona Chemical”); our ability to access adequate financing in order to fund the purchase price for the pending acquisition of all of the outstanding capital stock of Arizona Chemical (the “Arizona Chemical Acquisition”); debt payments, interest payments, benefit plan contributions, and income tax obligations; our anticipated 2015 capital expenditures, health, safety and environmental and infrastructure and maintenance projects, projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform; our ability to fully access our senior secured credit facilities; expectations regarding our counterparties’ ability to perform, including with respect to trade receivables; estimates regarding the tax expense of repatriating certain cash and short-term investments related to foreign operations; expectations regarding differentiated applications; our ability to realize certain deferred tax assets and our beliefs with respect to tax positions; expectations regarding our full year effective tax rate; estimates related to the useful lives of certain assets for tax purposes; expectations regarding our pension contributions for fiscal year 2015; estimates or expectations related to monomer costs, ending inventory levels and related estimated charges; the outcome and financial impact of legal proceedings; expectations regarding the spread between FIFO and ECRC in future periods; the estimates and matters described under the caption “Item 2. Management's Discussion and Analysis—Results of Operations—Outlook” and projections regarding environmental costs and capital expenditures and related operational savings. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward-looking statements. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this report. Further description of these risks and uncertainties and other important factors are set forth in this report, in our latest Annual Report on Form 10-K, including but not limited to “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” therein, and in our other filings with the Securities and Exchange Commission, and include, but are not limited to, risks related to:


•	failure to successfully close the Arizona Chemical Acquisition, or significant delays in closing the Arizona Chemical Acquisition;


•	failure to successfully integrate the business of Arizona Chemical, following the anticipated closing of the Arizona Chemical Acquisition;


•	failure to successfully achieve the expected synergies or significant delays in achieving such expected synergies in connection with the Arizona Chemical Acquisition;


•	our reliance on LyondellBasell Industries for the provision of significant operating and other services;


•	conditions in the global economy and capital markets;


•	the failure of our raw materials suppliers to perform their obligations under long-term supply agreements, or our inability to replace or renew these agreements when they expire;


•	limitations in the availability of raw materials we need to produce our products in the amounts or at the prices necessary for us to effectively and profitably operate our business;


•	significant fluctuations in raw material costs may result in volatility in our quarterly operating results and impact the market price of our common stock;


•	competition from other producers of styrenic block copolymers and from producers of products that can be substituted for our products;


•	our ability to produce and commercialize technological innovations;


•	our ability to protect our intellectual property, on which our business is substantially dependent;


•	the possibility that our products infringe upon the intellectual property rights of others;


•	a major failure of our information systems, which could harm our business;


•	seasonality in our business, particularly for sales into paving and roofing applications;


•	our substantial indebtedness, which could adversely affect our financial condition and prevent us from fulfilling our obligations under our current and future indebtedness;


•	financial and operating constraints related to our indebtedness;


•	the inherently hazardous nature of chemical manufacturing;


•	product liability claims and other lawsuits arising from environmental damage, personal injuries, other damages associated with chemical manufacturing or our products;


•	lawsuits arising from the termination of the Combination Agreement with LCY Chemical Corp.;


•	political, economic and local business risks in the various countries in which we operate;


•	health, safety and environmental laws, including laws that govern our employees’ exposure to chemicals deemed harmful to humans;


•	regulation of our company or our customers, which could affect the demand for our products or result in increased compliance and other costs;


•	customs, international trade, export control, antitrust, zoning and occupancy and labor and employment laws that could require us to modify our current business practices and incur increased costs;


•	fluctuations in currency exchange rates;


•	we may have additional tax liabilities;


•	our formation of a joint venture to expand hydrogenated styrenic block copolymers capacity in Asia;


•	our relationship with our employees;


•	loss of key personnel or our inability to attract and retain new qualified personnel;


•	the fact that we generally do not enter into long-term contracts with our customers;


•	a decrease in the fair value of our pension assets could require us to materially increase future funding requirements of the pension plan;


•	domestic or international natural disasters or terrorist attacks may disrupt our operations;


•	Delaware law and some provisions of our organizational documents that make a takeover of our company more difficult;


•	our expectation that we will not pay dividends for the foreseeable future; and


•	we are a holding company with nominal net worth and will depend on dividends and distributions from our subsidiaries to pay any dividends.

There may be other factors of which we are currently unaware or that we deem immaterial that may cause our actual results to differ materially from the expectations we express in our forward-looking statements. Although we believe the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and, therefore, also the forward-looking statements based on these assumptions could themselves prove to be inaccurate.

Forward-looking statements are based on current plans, estimates, assumptions and projections, and therefore you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them publicly in light of new information or future events.

Presentation of Financial Statements

The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. (“KPPI”) and its consolidated subsidiaries.

This Form 10-Q includes financial statements and related notes that present the condensed consolidated financial position, results of operations, comprehensive loss, and cash flows of Kraton. KPPI is a holding company whose only material asset is its investment in its wholly owned subsidiary, Kraton Polymers LLC. Kraton Polymers LLC and its subsidiaries own all of our consolidated operating assets.

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

Kraton Performance Polymers, Inc.:

We have reviewed the accompanying condensed consolidated balance sheet of Kraton Performance Polymers, Inc. and subsidiaries (the Company) as of September 30, 2015, the related condensed consolidated statements of operations, and comprehensive loss, for the three-month and nine-month periods ended September 30, 2015 and 2014, and the related condensed consolidated statements of changes in equity, and cash flows for the nine-month periods ended September 30, 2015 and 2014. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2014, and the related consolidated statements of operations, comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 25, 2015, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2014 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

/s/ KPMG LLP

Houston, Texas

October 29, 2015

PART I. FINANCIAL INFORMATION


Item 1.	Condensed Consolidated Financial Statements.

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)



	September 30, 2015			December 31, 2014
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	63,799		$	53,818
Receivables, net of allowances of $263 and $245	110,803			107,432
Inventories of products	264,105			326,992
Inventories of materials and supplies	11,345			10,968
Deferred income taxes	6,976			7,247
Other current assets	27,275			24,521
Total current assets	484,303			530,978
Property, plant and equipment, less accumulated depreciation of $376,294 and $387,463	493,711			451,765
Intangible assets, less accumulated amortization of $97,295 and $88,939	43,360			49,610
Investment in unconsolidated joint venture	11,725			12,648
Debt issuance costs	6,992			7,153
Deferred income taxes	2,973			2,176
Other long-term assets	21,335			28,122
Total assets	$	1,064,399		$	1,082,452
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	139		$	87
Accounts payable-trade	64,169			72,786
Other payables and accruals	66,604			50,888
Deferred income taxes	1,549			1,633
Due to related party	15,396			18,121
Total current liabilities	147,857			143,515
Long-term debt, net of current portion	404,799			351,785
Deferred income taxes	12,693			15,262
Other long-term liabilities	103,107			103,739
Total liabilities	668,456			614,301
Commitments and contingencies (note 11)
Equity:
Kraton stockholders' equity:
Preferred stock, $0.01 par value; 100,000 shares authorized; none issued	—			—
Common stock, $0.01 par value; 500,000 shares authorized; 30,524 shares issued and outstanding at September 30, 2015; 31,831 shares issued and outstanding at December 31, 2014	305			318
Additional paid in capital	347,462			361,342
Retained earnings	151,092			168,041
Accumulated other comprehensive loss	(138,005		)	(99,218		)
Total Kraton stockholders' equity	360,854			430,483
Noncontrolling interest	35,089			37,668
Total equity	395,943			468,151
Total liabilities and equity	$	1,064,399		$	1,082,452

See Notes to Condensed Consolidated Financial Statements

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)



	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
Revenue	$	269,012		$	318,971		$	786,349		$	954,394
Cost of goods sold	201,202			255,147			624,542			761,417
Gross profit	67,810			63,824			161,807			192,977
Operating expenses:
Research and development	7,597			7,440			23,345			23,736
Selling, general and administrative	26,917			16,374			77,488			78,872
Depreciation and amortization	16,145			16,552			46,852			49,630
Total operating expenses	50,659			40,366			147,685			152,238
Earnings of unconsolidated joint venture	95			80			273			324
Interest expense, net	6,151			6,099			17,975			18,667
Income (loss) before income taxes	11,095			17,439			(3,580		)	22,396
Income tax expense	3,076			1,122			4,135			3,405
Consolidated net income (loss)	8,019			16,317			(7,715		)	18,991
Net loss attributable to noncontrolling interest	(427		)	(298		)	(1,141		)	(858		)
Net income (loss) attributable to Kraton	$	8,446		$	16,615		$	(6,574	)	$	19,849
Earnings (loss) per common share:
Basic	$	0.27		$	0.51		$	(0.21	)	$	0.61
Diluted	$	0.27		$	0.50		$	(0.21	)	$	0.60
Weighted average common shares outstanding:
Basic	30,503			32,315			30,779			32,249
Diluted	30,849			32,600			30,779			32,590

See Notes to Condensed Consolidated Financial Statements

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)



	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
Net income (loss) attributable to Kraton	$	8,446		$	16,615		$	(6,574	)	$	19,849
Other comprehensive loss:
Foreign currency translation adjustments, net of tax of $0	(14,972		)	(28,587		)	(38,787		)	(25,651		)
Other comprehensive loss, net of tax	(14,972		)	(28,587		)	(38,787		)	(25,651		)
Comprehensive loss attributable to Kraton	(6,526		)	(11,972		)	(45,361		)	(5,802		)
Comprehensive loss attributable to noncontrolling interest	(2,717		)	(1,092		)	(2,579		)	(1,479		)
Consolidated comprehensive loss	$	(9,243	)	$	(13,064	)	$	(47,940	)	$	(7,281	)

See Notes to Condensed Consolidated Financial Statements

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)

(In thousands)



	Common Stock			Additional Paid in Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Total Kraton Stockholders' Equity			Noncontrolling Interest			Total Equity
Balance at December 31, 2013	$	325		$	363,590		$	170,827		$	(21,252	)	$	513,490		$	40,908		$	554,398
Net income (loss)	—			—			19,849			—			19,849			(858		)	18,991
Other comprehensive loss	—			—			—			(25,651		)	(25,651		)	(621		)	(26,272		)
Retired treasury stock from employee tax withholdings	—			(704		)	—			—			(704		)	—			(704		)
Exercise of stock options	1			1,428			—			—			1,429			—			1,429
Non-cash compensation related to equity awards	2			8,466			—			—			8,468			—			8,468
Balance at September 30, 2014	$	328		$	372,780		$	190,676		$	(46,903	)	$	516,881		$	39,429		$	556,310
Balance at December 31, 2014	$	318		$	361,342		$	168,041		$	(99,218	)	$	430,483		$	37,668		$	468,151
Net loss	—			—			(6,574		)	—			(6,574		)	(1,141		)	(7,715		)
Other comprehensive loss	—			—			—			(38,787		)	(38,787		)	(1,438		)	(40,225		)
Retired treasury stock from employee tax withholdings	—			(570		)	—			—			(570		)	—			(570		)
Retired treasury stock from share repurchases	(16		)	(20,930		)	(10,375		)	—			(31,321		)	—			(31,321		)
Exercise of stock options	1			1,021			—			—			1,022			—			1,022
Non-cash compensation related to equity awards	2			6,599			—			—			6,601			—			6,601
Balance at September 30, 2015	$	305		$	347,462		$	151,092		$	(138,005	)	$	360,854		$	35,089		$	395,943

See Notes to Condensed Consolidated Financial Statements

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)



	Nine months ended September 30,
	2015			2014
CASH FLOWS FROM OPERATING ACTIVITIES
Consolidated net income (loss)	$	(7,715	)	$	18,991
Adjustments to reconcile consolidated net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	46,852			49,630
Amortization of debt premium	(130		)	(121		)
Amortization of debt issuance costs	1,668			1,665
Gain on disposal of property, plant and equipment	(60		)	(33		)
Earnings from unconsolidated joint venture, net of dividends received	90			163
Deferred income tax benefit	(2,270		)	(3,222		)
Share-based compensation	6,601			8,468
Decrease (increase) in:
Accounts receivable	(9,693		)	(11,179		)
Inventories of products, materials and supplies	50,462			(28,796		)
Other assets	(2,022		)	(4,606		)
Increase (decrease) in:
Accounts payable-trade	(2,988		)	(30,007		)
Other payables and accruals	1,548			(5,915		)
Other long-term liabilities	1,536			(4,937		)
Due to related party	(2,306		)	(8,878		)
Net cash provided by (used in) operating activities	81,573			(18,777		)
CASH FLOWS FROM INVESTING ACTIVITIES
Kraton purchase of property, plant and equipment	(42,384		)	(47,539		)
KFPC purchase of property, plant and equipment	(46,097		)	(33,807		)
Purchase of software and other intangibles	(1,763		)	(2,724		)
Net cash used in investing activities	(90,244		)	(84,070		)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from debt	30,000			29,000
Repayments of debt	(30,000		)	(29,000		)
KFPC proceeds from debt	55,622			—
Capital lease payments	(99		)	(6,007		)
Purchase of treasury stock	(31,891		)	(704		)
Proceeds from the exercise of stock options	1,022			1,429
Debt issuance costs	—			(485		)
Net cash provided by (used in) financing activities	24,654			(5,767		)
Effect of exchange rate differences on cash	(6,002		)	(4,971		)
Net increase (decrease) in cash and cash equivalents	9,981			(113,585		)
Cash and cash equivalents, beginning of period	53,818			175,872
Cash and cash equivalents, end of period	$	63,799		$	62,287
Supplemental disclosures:
Cash paid during the period for income taxes, net of refunds received	$	5,435		$	9,267
Cash paid during the period for interest, net of capitalized interest	$	21,690		$	23,053
Capitalized interest	$	3,342		$	2,214
Supplemental non-cash disclosures:
Property, plant and equipment accruals	$	16,023		$	6,057
Asset acquired through capital lease	$	681		$	7,033

See Notes to Condensed Consolidated Financial Statements

KRATON PERFORMANCE POLYMERS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. General

Description of our Business. We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized over 50 years ago, that enhance the performance of numerous products by imparting greater flexibility, resilience, strength, durability and processability.

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins than more commoditized products. We refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products such as disposable diapers and the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex^TM isoprene rubber and isoprene rubber latex. Our Cariflex products are based on synthetic polyisoprene polymer and do not contain natural rubber latex or other natural rubber products making them an ideal substitute for natural rubber latex, particularly in applications with high purity requirements such as medical, healthcare, personal care and food contact. We believe the versatility of Cariflex products provides opportunities for new, differentiated applications.

We manufacture our polymers at five manufacturing facilities globally, including our flagship facility in Belpre, Ohio, as well as facilities in Germany, France, Brazil and Japan. The facility in Japan is operated by an unconsolidated manufacturing joint venture. The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries.

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements presented herein are for us and our consolidated subsidiaries, each of which is a wholly-owned subsidiary, except our 50% investment in our joint venture, Kraton Formosa Polymers Corporation (“KFPC”), located in Mailiao, Taiwan. KFPC is a variable interest entity for which we have determined that we are the primary beneficiary and, therefore, have consolidated into our financial statements. Our 50% investment in our joint venture located in Kashima, Japan is accounted for under the equity method of accounting. All significant intercompany transactions have been eliminated. These interim financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014 and reflect all normal recurring adjustments that are, in the opinion of management, necessary to present fairly our results of operations and financial position. Amounts reported in our Condensed Consolidated Statements of Operations are not necessarily indicative of amounts expected for the respective annual periods or any other interim period, in particular due to the effect of seasonal changes and weather conditions that typically affect our sales into paving and roofing applications.

Significant Accounting Policies. Our significant accounting policies have been disclosed in Note 1 Description of Business, Basis of Presentation and Significant Accounting Policies in our most recent Annual Report on Form 10-K. There have been no changes to the policies disclosed therein. The accompanying unaudited condensed consolidated financial statements we present in this report have been prepared in accordance with those policies.

Use of Estimates. The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant items subject to such estimates and assumptions include


•	the useful lives of fixed assets;


•	allowances for doubtful accounts and sales returns;


•	the valuation of derivatives, deferred tax assets, property, plant and equipment, inventory, investments and share-based compensation; and


•	liabilities for employee benefit obligations, environmental matters, asset retirement obligations (“ARO”), income tax uncertainties and other contingencies.

Income Tax in Interim Periods. We conduct operations in separate legal entities in different jurisdictions. As a result, income tax amounts are reflected in these condensed consolidated financial statements for each of those jurisdictions. Tax laws and tax rates vary substantially in these jurisdictions and are subject to change based on the political and economic climate in those countries. We file our tax returns in accordance with our interpretations of each jurisdiction’s tax laws. We record our tax provision or benefit on an interim basis using the estimated annual effective tax rate. This rate is applied to the current period ordinary income or loss to determine the income tax provision or benefit allocated to the interim period.

Losses from jurisdictions for which no benefit can be realized and the income tax effects of unusual and infrequent items are excluded from the estimated annual effective tax rate. Valuation allowances are provided against the future tax benefits that arise from the losses in jurisdictions for which no benefit can be realized. The effects of unusual and infrequent items are recognized in the impacted interim period as discrete items.

The estimated annual effective tax rate may be significantly affected by nondeductible expenses and by our projected earnings mix by tax jurisdiction. Adjustments to the estimated annual effective income tax rate are recognized in the period during which such estimates are revised.

We have established valuation allowances against a variety of deferred tax assets, including net operating loss carryforwards, foreign tax credits and other income tax credits. Valuation allowances take into consideration our expected ability to realize these deferred tax assets and reduce the value of such assets to the amount that is deemed more likely than not to be recoverable. Our ability to realize these deferred tax assets is dependent on achieving our forecast of future taxable operating income over an extended period of time. We review our forecast in relation to actual results and expected trends on a quarterly basis. If we fail to achieve our operating income targets, we may change our assessment regarding the recoverability of our net deferred tax assets and such change could result in a valuation allowance being recorded against some or all of our net deferred tax assets. A change in our valuation allowance would impact our income tax expense/benefit and our stockholders’ equity and could have a significant impact on our results of operations or financial condition in future periods.

2. New Accounting Pronouncements

Adoption of Accounting Standards

We have implemented all new accounting pronouncements that are in effect and that management believes would materially affect our financial statements.

New Accounting Standards

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. Recently, the effective date for the standard was deferred by one year and the standard is now effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted based on the original effective date. Our evaluation of this standard is currently ongoing and therefore, the effects of this standard on our financial position, results of operations and cash flows are not yet known.

In April 2015, the FASB issued ASU No. 2015-03, Interest-Imputation of Interest. This standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of such debt liability. In adopting ASU 2015-03, companies must apply the guidance on a retrospective basis. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015 and early adoption is permitted. We plan to adopt ASU 2015-03 in accordance with these requirements. We have assessed the impact of this new standard on our Condensed Consolidated Financial Statements and concluded that it would result in reductions of approximately $1.3 million, $5.3 million, and $6.6 million of other current assets, debt issuance costs, and long-term debt, respectively, as of September 30, 2015.

In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. This standard changes the measurement principle for inventory from the lower of cost or market to the lower of cost or net realizable value. ASU 2015-11 defines net realizable value as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance must be applied on a prospective basis and is effective for periods beginning after December 15, 2016, with early adoption permitted. Our evaluation of this standard is currently ongoing and therefore, the effects of this standard on our consolidated financial statements are not yet known.

In September 2015, the FASB issued ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. This standard requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. This includes recording in the reporting period the effect on earnings of changes in depreciation, amortization or other income effects as a result of the change to the provisional amounts as if the accounting had been completed at the acquisition date. The standard is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015 and early adoption is permitted. We plan to adopt this new standard in association with the pending Arizona Chemical Acquisition.

3. Pending Acquisition of Arizona Chemical

On September 27, 2015, Kraton Polymers LLC, one of our wholly owned subsidiaries, entered into a stock purchase agreement with Arizona Chemical, a leading global producer of high-value performance products and specialty chemicals derived from renewable raw materials, and AZC Holding Company LLC, the sole stockholder of Arizona Chemical Holdings Corporation (“Arizona Chemical”). Pursuant to the stock purchase agreement, we agreed to acquire all of the outstanding capital stock of Arizona Chemical for a cash purchase price of $1,370.0 million, subject to adjustment for cash and indebtedness at closing, as well as an adjustment for working capital and other items. The Arizona Chemical Acquisition is expected to close in late 2015 or early 2016, subject to certain customary closing conditions and the clearances and approvals under the rules of antitrust and competition law authorities in the United States, Germany, Russia and the Ukraine.

4. Share-Based Compensation

We account for share-based awards under the provisions of ASC 718, “Compensation—Stock Compensation.” Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award and we expense these costs using the straight-line method over the requisite service period. Share-based compensation expense was $2.0 million and $2.3 million for the three months ended September 30, 2015 and 2014, respectively, and $6.6 million and $8.5 million for the nine months ended September 30, 2015 and 2014, respectively.

5. Detail of Certain Balance Sheet Accounts



	September 30, 2015			December 31, 2014
	(In thousands)
Inventories of products:
Finished products	$	210,796		$	253,834
Work in progress	4,201			5,552
Raw materials	49,108			67,606
Total inventories of products	$	264,105		$	326,992
Other payables and accruals:
Employee related	$	22,832		$	16,156
Interest payable	2,171			7,959
Property, plant and equipment accruals	15,650			3,864
Other	25,951			22,909
Total other payables and accruals	$	66,604		$	50,888
Other long-term liabilities:
Pension and other postretirement benefits	$	91,418		$	86,605
Other	11,689			17,134
Total other long-term liabilities	$	103,107		$	103,739
Accumulated other comprehensive loss:
Foreign currency translation adjustments	$	(60,657	)	$	(21,870	)
Net unrealized loss on net investment hedge	(1,926		)	(1,926		)
Benefit plans liability	(75,422		)	(75,422		)
Total accumulated other comprehensive loss	$	(138,005	)	$	(99,218	)

6. Earnings Per Share (“EPS”)

Basic EPS is computed by dividing net income attributable to Kraton by the weighted-average number of shares outstanding during the period.

Diluted EPS is computed by dividing net income attributable to Kraton by the diluted weighted-average number of shares outstanding during the period and, accordingly, reflects the potential dilution that could occur if securities or other agreements to issue common stock, such as stock options, were exercised, settled or converted into common stock and were dilutive. The diluted weighted-average number of shares used in our diluted EPS calculation is determined using the treasury stock method.

Unvested awards of share-based payments with rights to receive dividends or dividend equivalents, such as our restricted stock awards, are considered to be participating securities, and therefore, the two-class method is used for purposes of calculating EPS. Under the two-class method, a portion of net income is allocated to these participating securities and is excluded from the calculation of EPS allocated to common stock. Our restricted stock awards are subject to forfeiture and restrictions on transfer until vested and have identical voting, income and distribution rights to the unrestricted common shares outstanding. Our weighted average restricted stock awards outstanding were 558,431 and 491,926 for the three months ended September 30, 2015 and 2014, respectively, and 553,400 and 491,684 for the nine months ended September 30, 2015 and 2014, respectively. We withheld shares of restricted stock upon vesting to satisfy employee payroll tax withholding requirements totaling 0 and 1,793 for the three months ended September 30, 2015 and 2014, respectively, and 27,947 and 27,173 for the nine months ended September 30, 2015 and 2014, respectively. We immediately retired all shares withheld and the transactions were reflected in additional paid in capital in the Condensed Consolidated Statements of Changes in Equity and as a purchase of treasury stock in the Condensed Consolidated Statements of Cash Flows.

The computation of diluted EPS includes weighted average restricted share units of 143,204 and 87,696 for the three months ended September 30, 2015 and 2014, respectively, and 0 and 80,335 for the nine months ended September 30, 2015 and 2014, respectively. The computation of diluted EPS excludes weighted average restricted share units of 133,317 for the nine months ended September 30, 2015 as they are anti-dilutive due to a net loss attributable to Kraton for the period.

The computation of diluted EPS includes weighted average performance share units of 32,498 and 34,811 for the three months ended September 30, 2015 and 2014, respectively, and 0 and 27,032 for the nine months ended September 30, 2015 and 2014, respectively. The computation of diluted EPS excludes weighted average performance share units of 33,564 for the nine months ended September 30, 2015 as they are anti-dilutive due to a net loss attributable to Kraton for the period. In addition, the computation of diluted earnings per share also excludes the effect of performance share units for which the performance contingencies had not been met as of the reporting date, amounting to 279,328 for the three and nine months ended September 30, 2015 and 102,396 for the three and nine months ended September 30, 2014.

The computation of diluted EPS includes stock options added under the treasury stock method, which amounted to 170,602 and 162,049 for the three months ended September 30, 2015 and 2014, respectively, and 0 and 233,594 for the nine months ended September 30, 2015 and 2014, respectively. The computation of diluted EPS excludes the effect of the potential exercise of stock options that are anti-dilutive, amounting to 906,954 and 1,008,497 for the three months ended September 30, 2015 and 2014, respectively, and 1,472,988 and 987,843 for the nine months ended September 30, 2015 and 2014, respectively.

The calculations of basic and diluted EPS are as follows:



	Three months ended September 30, 2015							Three months ended September 30, 2014
	Net Income Attributable to Kraton			Weighted Average Shares Outstanding		Earnings Per Share		Net Income Attributable to Kraton			Weighted Average Shares Outstanding		Earnings Per Share
	(In thousands, except per share data)							(In thousands, except per share data)
Basic:
As reported	$	8,446		31,061				$	16,615		32,807
Amounts allocated to unvested restricted shares	(152		)	(558	)			(249		)	(492	)
Amounts available to common stockholders	8,294			30,503		$	0.27	16,366			32,315		$	0.51
Diluted:
Amounts allocated to unvested restricted shares	152			558				249			492
Non participating share units	—			175				—			123
Stock options added under the treasury stock method	—			171				—			162
Amounts reallocated to unvested restricted shares	(150		)	(558	)			(247		)	(492	)
Amounts available to stockholders and assumed conversions	$	8,296		30,849		$	0.27	$	16,368		32,600		$	0.50



	Nine months ended September 30, 2015								Nine months ended September 30, 2014
	Net Loss Attributable to Kraton			Weighted Average Shares Outstanding		Loss Per Share			Net Income Attributable to Kraton			Weighted Average Shares Outstanding		Earnings Per Share
	(In thousands, except per share data)								(In thousands, except per share data)
Basic:
As reported	$	(6,574	)	31,332					$	19,849		32,741
Amounts allocated to unvested restricted shares	116			(553	)				(298		)	(492	)
Amounts available to common stockholders	(6,458		)	30,779		$	(0.21	)	19,551			32,249		$	0.61
Diluted:
Amounts allocated to unvested restricted shares	(116		)	553					298			492
Non participating share units	—			—					—			107
Stock options added under the treasury stock method	—			—					—			234
Amounts reallocated to unvested restricted shares	116			(553	)				(295		)	(492	)
Amounts available to stockholders and assumed conversions	$	(6,458	)	30,779		$	(0.21	)	$	19,554		32,590		$	0.60

Share Repurchase Program. On October 27, 2014, our board of directors approved a share repurchase program which allowed for the repurchase of outstanding shares of our common stock having an aggregate purchase price of up to $50.0 million. We repurchased shares of our common stock in the open market at prevailing market prices and through a trading program under Rule 10b5-1. During the three months ended September 30, 2015, we repurchased 827,142 shares of our common stock at an average price of $20.77 per share and a total cost of $17.2 million (including trading commissions). From the inception of the program through September 30, 2015, we repurchased a total of 2,549,683 shares of our common stock at an average price of $19.58 per share and a total cost of $50.0 million (including trading commissions). The share repurchase program was financed with available cash and the program is now complete.

7. Long-Term Debt

Long-term debt consists of the following:



	September 30, 2015		December 31, 2014
	(In thousands)
6.75% unsecured notes	$	350,695	$	350,825
KFPC loan agreement	52,575		—
Capital lease obligation	1,668		1,047
Total debt	404,938		351,872
Less current portion of total debt	139		87
Long-term debt	$	404,799	$	351,785

Senior Secured Credit Facilities. In March 2013, we entered into an asset-based revolving credit facility consisting of a $150.0 million U.S. senior secured revolving credit facility (the “U.S. Facility”) and a $100.0 million Dutch senior secured revolving credit facility (the “Dutch Facility,” and together with the U.S. Facility, the “Senior Secured Credit Facilities”). Borrowing under the Senior Secured Credit Facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security.

We may request up to an aggregate of $100.0 million of additional revolving facility commitments of which up to an aggregate of $40.0 million may be additional Dutch Facility commitments, provided that we satisfy additional conditions described in the Senior Secured Credit Facilities, and provided further that the commitment under the U.S. Facility is at least 60% of the commitments after giving effect to such increase.

Kraton Polymers U.S. LLC and Kraton Polymers Nederland B.V. are the borrowers under the Senior Secured Credit Facilities, and Kraton Performance Polymers, Inc., Kraton Polymers LLC, Elastomers Holdings LLC and Kraton Polymers Capital Corporation are the guarantors for both the U.S. Facility and the Dutch Facility. In addition, K.P. Global Holdings C.V. and Kraton Polymers Holdings B.V. are guarantors for the Dutch Facility. The Senior Secured Credit Facilities terminate on March 27, 2018; however, we may from time to time request that the lenders extend the maturity of their commitments. Availability under the Senior Secured Credit Facilities is limited to the lesser of the borrowing base and total commitments (less certain reserves).

The Senior Secured Credit Facilities are primarily secured by receivables and inventory. The U.S. Facility provides for borrowings in the United States and is secured by assets located in the United States. The Dutch Facility provides for borrowings outside of the United States and is secured by assets located outside of the United States.

Borrowings under the U.S. Facility (other than swingline loans) bear interest at a rate equal to, at the applicable borrower’s option, either (a) a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.5% and (3) LIBOR plus 1.0%, or (b) a rate based on LIBOR, in each case plus an applicable margin. U.S. swingline loans shall bear interest at a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.5% or (3) LIBOR plus 1.0%, in each case plus an applicable margin.

Borrowings under the Dutch Facility (other than swingline loans) bear interest at a rate equal to, at the applicable borrower’s option, either (a) a fluctuating rate, with respect to Euros, Pounds Sterling and Dollars outside of the U.S. and Canada, equal to the rate announced by the European Central Bank and used as a base rate by the local branch of Bank of America in the jurisdiction in which such currency is funded, or (b) a rate based on LIBOR, in each case plus an applicable margin. Dutch swingline loans shall bear interest at a fluctuating rate, with respect to Euros, Pounds Sterling and Dollars outside of the U.S. and Canada, equal to the rate announced by the European Central Bank and used as a base rate by the local branch of Bank of America in the jurisdiction in which such currency is funded.

The applicable margin is subject to a minimum of 0.5% and a maximum of 1.0% with respect to U.S. base rate loans, and a minimum of 1.5% and maximum of 2.0% for foreign base rate borrowings, and a minimum of 1.5% and maximum of 2.0% for both U.S. and foreign LIBOR loans and is subject to adjustment based on the borrowers’ excess availability of the applicable facility for the most recent fiscal quarter. Our effective interest rate for borrowings on the Senior Secured Credit Facilities was 3.75% and 2.04% for the three and nine months ended September 30, 2015, respectively.

In addition to paying interest on outstanding principal amounts under the Senior Secured Credit Facilities, the borrowers will be required to pay a commitment fee in respect of the unutilized commitments at an annual rate of 0.375%.

The Senior Secured Credit Facilities contain a financial covenant that if either (a) excess availability is less than the greater of (i) 12.5% of the lesser of the commitments and the borrowing base and (ii) $31,250,000 or (b) U.S. availability is less than the greater of (i) 12.5% of the lesser of the U.S. commitments and U.S. borrowing base and (ii) $18,750,000, then following such event, Kraton and its restricted subsidiaries must maintain a fixed charge coverage ratio of at least 1.0 to 1.0 for four fiscal quarters (or for a shorter duration if certain financial conditions are met). The Senior Secured Credit Facilities contain certain customary events of default, including, without limitation, a failure to make payments under the facility, cross-default and cross-judgment default, certain bankruptcy events and certain change of control events.

As of September 30, 2015, our total borrowing capacity was $169.6 million of which none was drawn. As of October 26, 2015, our total borrowing capacity was $167.8 million, of which none was drawn.

6.75% Senior Notes due 2019. Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019 pursuant to an indenture dated February 11, 2011 as amended and supplemented by a supplemental indenture thereto dated March 20, 2012 (collectively, the “Indenture”). The Indenture provides that the notes are general unsecured, senior obligations and will be unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year.

Capital Lease. In January 2014, we entered into a 10 year capital lease with a principal amount of $7.0 million to fund a portion of our capital expenditures. In March 2015, this capital lease increased by $0.7 million based on final project construction costs.

KFPC Loan Agreement. On July 17, 2014, KFPC executed a syndicated loan agreement (the “KFPC Loan Agreement”) in the amount of 5.5 billion New Taiwan Dollars (“NTD”), or $166.3 million (converted at the September 30, 2015 exchange rate), to provide additional funding to construct the hydrogenated styrenic block copolymer (“HSBC”) facility in Taiwan and to provide funding for working capital requirements and/or general corporate purposes.

The KFPC Loan Agreement is comprised of a NTD 4.29 billion Tranche A, or $129.7 million (converted at the September 30, 2015 exchange rate), to fund KFPC’s capital expenditures, and a NTD 1.21 billion Tranche B, or $36.6 million (converted at the September 30, 2015 exchange rate), to fund working capital requirements and/or general corporate purposes. As of September 30, 2015, NTD 1.7 billion, or $52.6 million (converted at the September 30, 2015 exchange rate) was drawn on the KFPC Loan Agreement. The facility period of the KFPC Loan Agreement is five years from January 17, 2015 (the first drawdown date). KFPC may continue to draw on the KFPC Loan Agreement for the first 28 months following the first drawdown date. Subject to certain conditions, KFPC can request a two-year extension of the facility period of the KFPC Loan Agreement.

The total outstanding principal amount is payable in six semi-annual installments with the first payment due on July 17, 2017 and each subsequent payment due every six months thereafter. The first five installments shall be in an amount equal to 10% of the outstanding principal amount and the final installment shall be in an amount equal to the remaining 50% of the outstanding principal amount. In the event the extension period is granted, the final 50% of the outstanding principal amount shall be repaid in five equal semi-annual installments with the first installment due on the original final maturity date.

The KFPC Loan Agreement is subject to a variable interest rate composed of a fixed 0.8% margin plus the three-month or six-month fixing rate of the Taipei Interbank Offered Rate (depending on the interest period as selected by KFPC in the drawdown request or the interest period notice), subject to a floor of 1.7%. Interest is payable on a monthly basis. For the three and nine months ended September 30, 2015, our effective interest rate for borrowings on the KFPC Loan Agreement was 1.80%.

The KFPC Loan Agreement contains certain financial covenants which change during the term of the KFPC Loan Agreement. The financial covenants include a maximum debt to equity ratio of 3.0 to 1.0 commencing in 2014, which will decrease over time to 1.2 to 1.0 in 2018; a minimum tangible net worth requirement of $50.0 million commencing in 2014, which will increase to $100.0 million in 2019; and a minimum interest coverage ratio of 2.5 to 1.0 commencing in 2016, which will increase to 5.0 to 1.0 in 2017. In each case, these covenants are calculated and tested on an annual basis. Formosa Petrochemical Corporation and Kraton Polymers LLC are the guarantors of the KFPC Loan Agreement with each guarantor guaranteeing 50% of the indebtedness.

Debt Maturities. The remaining principal payments on our outstanding total debt as of September 30, 2015, are as follows:



	Principal Payments
	(In thousands)
September 30:
2016	$	139
2017	5,405
2018	10,672
2019	360,682
2020	26,464
Thereafter	881
Total debt	$	404,243

See Note 9 Fair Value Measurements, Financial Instruments and Credit Risk for fair value information related to our long-term debt.

8. Debt Issuance Costs

We capitalize the debt issuance costs related to issuing long-term debt and amortize these costs using the effective interest method, except for costs related to revolving debt, which are amortized using the straight-line method. Amortization of debt issuance costs and the accelerated write-off of debt issuance costs in connection with refinancing activities are recorded as a component of interest expense. We had net debt issuance costs of $9.4 million and $9.5 million (of which $2.4 million and $2.3 million were included in other current assets) as of September 30, 2015 and December 31, 2014, respectively. During the year ended December 31, 2014, our consolidated joint venture, KFPC, capitalized $0.5 million of debt issuance costs related to the KFPC Loan Agreement executed in July 2014. During the three months ended September 30, 2015, we capitalized $1.7 million of debt issuance costs related to the potential debt financing associated with the Arizona Chemical Acquisition which is expected to occur in late 2015 or early 2016. See Note 3 Pending Acquisition, for further discussion of the pending Arizona Chemical Acquisition. We amortized $0.6 million and $0.6 million of debt issuance costs for the three months ended September 30, 2015 and 2014, respectively, and $1.7 million and $1.7 million of debt issuance costs for the nine months ended September 30, 2015 and 2014, respectively.

9. Fair Value Measurements, Financial Instruments and Credit Risk

ASC 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. ASC 820 requires entities to, among other things, maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions.

In accordance with ASC 820, these two types of inputs have created the following fair value hierarchy:


•	Level 1—Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets;


•	Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:


•	Quoted prices for similar assets or liabilities in active markets


•	Quoted prices for identical or similar assets or liabilities in markets that are not active


•	Inputs other than quoted prices that are observable for the asset or liability


•	Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and


•	Level 3—Inputs that are unobservable and reflect our assumptions used in pricing the asset or liability based on the best information available under the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

Recurring Fair Value Measurements. The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2015 and December 31, 2014. These financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment, which judgment may affect the valuation of their fair value and their placement within the fair value hierarchy levels.



				Fair Value Measurements at Reporting Date Using
	Balance Sheet Location	September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
		(In thousands)
Retirement plan asset – current	Other current assets	$	272	$	272	$	—	$	—
Retirement plan asset – noncurrent	Other long-term assets	$	2,264	$	2,264	$	—	$	—
Total		$	2,536	$	2,536	$	—	$	—



				Fair Value Measurements at Reporting Date Using
	Balance Sheet Location	December 31, 2014		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
		(In thousands)
Retirement plan asset – current	Other current assets	$	272	$	272	$	—	$	—
Retirement plan asset – noncurrent	Other long-term assets	$	2,055	$	2,055	$	—	$	—
Total		$	2,327	$	2,327	$	—	$	—

The following table presents the carrying values and approximate fair values of our long-term debt.



	September 30, 2015				December 31, 2014
	Carrying Value		Fair Value		Carrying Value		Fair Value
	(In thousands)				(In thousands)
6.75% unsecured notes (quoted prices in active market for identical assets – level 1)	$	350,695	$	350,000	$	350,825	$	358,750
Capital lease obligation (significant other observable inputs – level 2)	$	1,668	$	1,668	$	1,047	$	1,047

Financial Instruments

Foreign Currency Hedges. Periodically, we enter into foreign currency agreements to hedge or otherwise protect against fluctuations in foreign currency exchange rates. These agreements do not qualify for hedge accounting and gains/losses resulting from both the up-front premiums and/or settlement of the hedges at expiration of the agreements are recognized in the period in which they are incurred. For the three months ended September 30, 2015 and 2014, we settled these hedges and recorded a loss of $1.9 million and a loss of $3.9 million, respectively, and for the nine months ended September 30, 2015 and 2014, we recorded a loss of $5.9 million and a loss of $4.3 million, respectively, which are recorded in cost of goods sold. These contracts are structured such that these gains/losses from the mark-to-market impact of the hedging instruments materially offset the underlying foreign currency exchange gains/losses to reduce the overall impact of foreign currency exchange movements throughout the period.

Credit Risk

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts, which we seek to minimize by limiting our counterparties to major financial institutions with acceptable credit ratings and by monitoring the total value of positions with individual counterparties. In the event of a default by one of our counterparties, we may not receive payments provided for under the terms of our derivatives.

We analyze our counterparties’ financial condition prior to extending credit and we establish credit limits and monitor the appropriateness of those limits on an ongoing basis. We also obtain cash, letters of credit or other acceptable forms of security from customers to provide credit support, where appropriate, based on our financial analysis of the customer and the contractual terms and conditions applicable to each transaction.

10. Income Taxes

Income tax expense was $3.1 million and $1.1 million for the three months ended September 30, 2015 and 2014, respectively, and $4.1 million and $3.4 million for the nine months ended September 30, 2015 and 2014, respectively. Our effective tax rate was 27.7% and 6.4% for the three months ended September 30, 2015 and 2014, respectively, and (115.5)% and 15.2% for the nine months ended September 30, 2015 and 2014, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the reasons set forth below:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Income taxes at the statutory rate	35.0	%	35.0	%	35.0	%	35.0	%
Foreign tax rate differential	(32.7	)%	(13.1	)%	109.5	%	(16.8	)%
Permanent differences	4.6	%	3.7	%	(43.2	)%	8.4	%
Uncertain tax positions	1.6	%	1.0	%	(13.7	)%	2.9	%
Valuation allowance	24.3	%	(26.4	)%	(226.0	)%	(20.6	)%
Return to provision adjustments	(4.7	)%	5.2	%	13.5	%	5.9	%
Other	(0.4	)%	1.0	%	9.4	%	0.4	%
Effective tax rate	27.7	%	6.4	%	(115.5	)%	15.2	%

We record a valuation allowance when it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. As of September 30, 2015 and December 31, 2014, a valuation allowance of $97.4 million and $90.4 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We increased our valuation allowance by $2.7 million for the three months ended September 30, 2015 primarily related to current period net operating losses in the U.S. tax jurisdiction. We decreased our valuation allowance by $4.4 million for the three months ended September 30, 2014, of which $2.5 million represents utilization of net operating losses in the current period and $1.9 million relates to the assessment of our ability to utilize net operating losses in future periods. We increased our valuation allowance by $7.0 million for the nine months ended September 30, 2015, which includes $8.1 million related to current period net operating losses, partially offset by a $1.1 million decrease related to changes in other comprehensive income (loss). We decreased our valuation allowance by $4.6 million for the nine months ended September 30, 2014, of which $2.7 million represents utilization of net operating losses in the current period and $1.9 million relates to the assessment of our ability to utilize net operating losses in future periods. Excluding the change in our valuation allowance, our effective tax rate would have been a 3.4% expense and a 31.7% expense for the three months ended September 30, 2015 and 2014, respectively, and a 110.5% benefit and a 35.8% expense for the nine months ended September 30, 2015, and 2014, respectively.

As of September 30, 2015 and December 31, 2014, we had total unrecognized tax benefits of $4.8 million and $4.7 million, respectively, related to uncertain foreign tax positions, all of which, if recognized, would impact our effective tax rate. During the three months ended September 30, 2015 and 2014, we had an increase in uncertain tax positions of $0.2 million and a decrease of $0.3 million, respectively, and an increase of $0.2 million and an increase of $0.2 million during the nine months ended September 30, 2015, and 2014, respectively, primarily related to uncertain tax positions in Europe. We recorded interest and penalties related to unrecognized tax benefits within the provision for income taxes. We believe that no current tax positions that have resulted in unrecognized tax benefits will significantly increase or decrease within one year.

We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. For our U.S. federal income tax returns, the statute of limitations has expired through the tax year ended December 31, 2003. As a result of net operating loss carryforwards from 2004, the statute of limitations remains open for all years subsequent to 2003. In addition, open tax years for state and foreign jurisdictions remain subject to examination.

11. Commitments and Contingencies

(a) Legal Proceedings

We received notice from the tax authorities in Brazil assessing R$6.1 million, or $1.5 million (converted at the September 30, 2015 exchange rate), in connection with tax credits that were generated from the purchase of certain goods which were subsequently applied by us against taxes owed. We have appealed the assertion by the tax authorities in Brazil that the goods purchased were not eligible to earn the credits. While the outcome of this proceeding cannot be predicted with certainty, we do not expect this matter to have a material adverse effect upon our financial position, results of operations or cash flows.

On January 28, 2014, we executed a definitive agreement (the “Combination Agreement”) to combine with the SBC operations of Taiwan-based LCY Chemical Corp. (“LCY”). The Combination Agreement called for LCY to contribute its SBC business in exchange for newly issued shares in the combined company, such that our existing stockholders and LCY would each own 50% of the outstanding shares of the combined enterprise.

On June 30, 2014, we notified LCY that our Board of Directors intended to withdraw its recommendation to our stockholders to approve the Combination Agreement unless the parties could agree upon mutually acceptable revised terms to the Combination Agreement. This notice cited the decline in operating results for LCY’s SBC business in the first quarter of 2014 and a related decline in forecasted results thereafter, together with the decline in our stock price and negative reactions from our stockholders. Following our notification of our Board’s intention to change its recommendation, the parties engaged in discussions to determine whether they could mutually agree to changes to the terms of the Combination Agreement that would enable our Board to continue to recommend that our stockholders approve the Combination Agreement. The parties engaged in numerous discussions subsequent to June 30, 2014 regarding possible revisions to the terms of the Combination Agreement.

On July 31, 2014, an explosion occurred in a pipeline owned by LCY in Kaohsiung, Taiwan, causing substantial property damage and loss of life, and numerous governmental and private investigations and claims have been initiated and asserted against LCY. On August 4, 2014, LCY notified us that it would no longer negotiate, and would not agree to, any revisions to the terms of the Combination Agreement. On August 6, 2014, our Board withdrew its recommendation that our stockholders approve the Combination Agreement. On August 8, 2014, we received notice from LCY that LCY had exercised its right to terminate the Combination Agreement.

The provisions of the Combination Agreement provide for us to pay LCY a $25 million break-up fee upon a termination of the Combination Agreement following a withdrawal of our Board’s recommendation, unless an LCY material adverse effect has occurred and is continuing at the time of the withdrawal of our Board’s recommendation. In LCY’s notice terminating the Combination Agreement, LCY requested payment of such $25 million termination fee. On October 6, 2014, LCY filed a lawsuit against us in connection with our refusal to pay the $25 million termination fee. We believe that the impact upon LCY of the July 31, 2014 explosion in a gas pipeline in Kaohsiung, Taiwan, constitutes an LCY material adverse effect as defined in the Combination Agreement, and we have notified LCY that accordingly we are not obligated to pay the termination fee. On July 23, 2015, LCY's lawsuit was dismissed from the Delaware federal court on jurisdictional grounds. LCY has the right to re-file its suit in Delaware state court. As of the date of this filing, they had not re-filed their suit. While the ultimate resolution of this matter cannot be predicted with certainty, we do not expect any material adverse effect upon our financial position, results of operations or cash flows from the ultimate outcome of this matter.

We and certain of our subsidiaries, from time to time, are parties to various other legal proceedings, claims and disputes that have arisen in the ordinary course of business. These claims may involve significant amounts, some of which would not be covered by insurance. A substantial settlement payment or judgment in excess of our accruals could have a material adverse effect on our financial position, results of operations or cash flows. While the outcome of these proceedings cannot be predicted with certainty, we do not expect any of these existing matters, individually or in the aggregate, to have a material adverse effect upon our financial position, results of operations or cash flows.

(b) Asset Retirement Obligations.

The changes in the aggregate carrying amount of our ARO liability are as follows:



	Nine months ended September 30,
	2015			2014
	(In thousands)
Beginning balance	$	10,394		$	10,497
Accretion expense	319			403
Obligations settled	(25		)	(73		)
Foreign currency translation, net	(306		)	(362		)
Ending Balance	$	10,382		$	10,465

For a portion of our ARO liability related to the decommissioning of the coal boilers at our Belpre, Ohio, facility, we have recorded a $3.6 million receivable from Shell Chemicals as of September 30, 2015 pursuant to the indemnity included in the February 2001 separation agreement, which serves to offset the related ARO asset which is included in property, plant and equipment.

In the first quarter of 2014, we experienced weather-related downtime at our Belpre, Ohio, facility. In addition, our facility in Berre, France, experienced an operating disruption resulting from a small fire that impacted one of the production lines at this facility. We incurred $12.0 million of costs in the nine months ended September 30, 2014 associated with these two events. In the third quarter 2014, we recorded a $1.0 million reduction of costs due to the confirmation of a partial insurance recovery which is included in receivables as of September 30, 2014. Through September 30, 2015, we have received insurance recoveries totaling $2.2 million.

(d) Contingent Fees Associated with Arizona Chemical Acquisition

We have engaged with certain third-parties for services related to the Arizona Chemical Acquisition in exchange for fees that are contingent upon the successful financing and closing of the transaction. These fees have not been accrued as of September 30, 2015 and are expected to be payable at closing.

There have been no other material changes to our Commitments and Contingencies disclosed in our most recently filed Annual Report on Form 10-K.

12. Employee Benefits

Retirement Plans.

The components of net periodic benefit cost related to U.S. pension benefits are as follows:



	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
	(In thousands)						(In thousands)
Service cost	$	883		$	700		$	2,648		$	2,100
Interest cost	1,620			1,543			4,860			4,628
Expected return on plan assets	(2,115		)	(1,918		)	(6,345		)	(5,753		)
Amortization of prior service cost	1,060			460			3,180			1,380
Net periodic benefit cost	$	1,448		$	785		$	4,343		$	2,355

We made contributions of $1.1 million and $7.2 million to our pension plan in the nine months ended September 30, 2015 and 2014, respectively.

The components of net periodic benefit cost related to other post-retirement benefits are as follows:



	Three months ended September 30,				Nine months ended September 30,
	2015		2014		2015		2014
	(In thousands)				(In thousands)
Service cost	$	150	$	140	$	450	$	375
Interest cost	318		348		953		953
Amortization of prior service cost	190		155		570		315
Net periodic benefit cost	$	658	$	643	$	1,973	$	1,643

13. Industry Segment and Foreign Operations

We operate in one segment for the manufacturing and marketing of engineered polymers. In accordance with the provisions of ASC 280, “Segment Reporting,” our chief operating decision-maker has been identified as the President and Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Since we operate in one segment and in one group of similar products, all financial segment and product line information required by ASC 280 can be found in the condensed consolidated financial statements.

Our products are manufactured and our commercial activities are organized in the following product groups based upon polymer chemistry and process technologies:



	Three months ended September 30,				Nine months ended September 30,
	2015		2014		2015		2014
	(In thousands)				(In thousands)
Revenue:
Performance Products	$	147,987	$	180,122	$	420,889	$	531,948
Specialty Polymers	86,828		98,742		263,082		317,551
Cariflex	34,044		39,959		102,069		104,564
Other	153		148		309		331
	$	269,012	$	318,971	$	786,349	$	954,394

For geographic reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. Long-lived assets consist primarily of property, plant and equipment, which are attributed to the geographic location in which they are located and are presented at historical cost.

Following is a summary of revenue by geographic region:



	Three months ended September 30,				Nine months ended September 30,
	2015		2014		2015		2014
	(In thousands)				(In thousands)
Revenue:
United States	$	87,507	$	95,816	$	249,674	$	298,434
Germany	32,485		45,380		92,188		125,992
China	20,759		19,212		61,475		58,517
Japan	18,096		24,224		52,877		61,706
Thailand	14,513		15,155		38,148		42,339
Brazil	7,079		11,867		25,774		38,375
France	7,932		10,644		24,489		34,654
United Kingdom	8,638		8,893		23,838		27,313
Malaysia	7,705		7,877		23,657		19,944
Italy	5,257		8,299		19,875		25,865
Belgium	6,183		8,544		18,953		33,830
Netherlands	5,881		6,673		17,711		19,959
Canada	4,296		3,652		11,964		12,316
Sweden	3,973		4,248		11,667		15,169
South Korea	2,819		2,786		10,471		10,681
Taiwan	3,107		4,021		10,429		14,690
Mexico	2,374		5,338		9,636		13,548
Turkey	3,193		3,054		8,369		9,606
Argentina	2,783		2,721		7,529		11,317
Denmark	2,245		1,988		6,991		6,280
Austria	2,399		4,058		6,845		10,508
All other countries	$	19,788	$	24,521	$	53,789	$	63,351
	$	269,012	$	318,971	$	786,349	$	954,394

Following is a summary of long-lived assets by geographic region:



	September 30, 2015		December 31, 2014
	(In thousands)
Long-lived assets, at cost:
United States	$	490,522	$	495,313
France	112,727		115,987
Taiwan	112,218		56,994
Germany	57,366		60,022
Brazil	55,422		71,970
Netherlands	32,744		29,838
China	7,040		7,273
Japan	1,788		1,637
All other countries	178		194
	$	870,005	$	839,228

14. Related Party Transactions

We own a 50% equity investment in a SBC manufacturing joint venture in Kashima, Japan. Our due to related party liability on the condensed consolidated balance sheet is related to this joint venture and the purchases from the joint venture amounted to $7.6 million and $9.4 million for the three months ended September 30, 2015 and 2014, respectively, and $22.4 million and $30.0 million for the nine months ended September 30, 2015 and 2014, respectively.

We own a 50% variable interest in KFPC, a HSBC manufacturing joint venture in Mailiao, Taiwan. The KFPC joint venture is fully consolidated in our financial statements, and our joint venture partner, Formosa Petrochemical Corporation (“FPCC”), is a related party affiliate. Under the terms of the joint venture agreement, FPCC is to provide certain site services and raw materials to KFPC. Charges from and amounts due to FPCC are immaterial through the period ended September 30, 2015. See Note 15 Variable Interest Entity, for further discussion related to the KFPC joint venture.

15. Variable Interest Entity

We hold a variable interest in a joint venture with FPCC to build, own and operate a 30 kiloton HSBC plant at FPCC’s petrochemical site in Mailiao, Taiwan. Kraton and FPCC are each 50% owners of the joint venture company, KFPC. Under the provisions of an offtake agreement with KFPC, we have exclusive rights to purchase all production from KFPC. Additionally, the agreement requires us to purchase a minimum of eighty percent of the plant production capacity each year at a defined fixed margin. This offtake agreement represents a variable interest which provides us the power to direct the most significant activities of KFPC and exposes us to the economic variability of the joint venture. As such, we have determined that we are the primary beneficiary of this variable interest entity; and therefore, we have consolidated KFPC in our financial statements and reflected FPCC’s 50% percent ownership as a noncontrolling interest.

The following table summarizes the carrying amounts of assets and liabilities as of September 30, 2015 and December 31, 2014 for KFPC before intercompany eliminations. See Note 7 Long Term Debt, for further discussion related to the KFPC Loan Agreement executed on July 17, 2014.



	September 30, 2015		December 31, 2014
	(In thousands)
Cash and cash equivalents	$	10,986	$	7,993
Other current assets	5,222		2,533
Property, plant and equipment	112,066		56,904
Intangible assets	9,200		9,579
Other long-term assets	1,404		1,098
Total assets	$	138,878	$	78,107
Current liabilities	16,126		2,771
Long-term debt	52,575		—
Total liabilities	$	68,701	$	2,771

16. Subsequent Events

We have evaluated significant events and transactions that occurred after the balance sheet date and determined that there were no other events or transactions that would require recognition or disclosure in our condensed consolidated financial statements for the period ended September 30, 2015.

17. Supplemental Guarantor Information

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, (“the Issuers”), are co-issuers of the 6.75% senior notes due March 1, 2019. The 6.75% senior notes are fully and unconditionally guaranteed on a joint and several basis by KPPI, the parent company of the Issuers, and Elastomers Holdings LLC, which is a U.S. holding company and a 100% owned subsidiary of Kraton Polymers LLC, collectively, (“the Guarantors”). Our remaining subsidiaries are not guarantors of the 6.75% senior notes. We do not believe that separate financial statements and other disclosures concerning the guarantor subsidiaries would provide any additional information that would be material to investors in making an investment decision.

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

September 30, 2015

(Unaudited)

(In thousands, except par value)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	—		$	1,258		$	62,541		$	—		$	63,799
Receivables, net of allowances	—		304			39,376			71,123			—			110,803
Inventories of products	—		(2,687		)	154,431			112,361			—			264,105
Inventories of materials and supplies	—		—			9,734			1,611			—			11,345
Deferred income taxes	—		3,566			—			3,410			—			6,976
Other current assets	—		4,068			4,377			18,830			—			27,275
Total current assets	—		5,251			209,176			269,876			—			484,303
Property, plant and equipment, less accumulated depreciation	—		38,263			253,797			201,651			—			493,711
Intangible assets, less accumulated amortization	—		40,855			1,908			597			—			43,360
Investment in consolidated subsidiaries	498,859		1,425,052			—			—			(1,923,911		)	—
Investment in unconsolidated joint venture	—		813			—			10,912			—			11,725
Debt issuance costs	—		5,339			865			788			—			6,992
Deferred income taxes	—		390			—			2,583			—			2,973
Other long-term assets	—		27,296			653,008			88,643			(747,612		)	21,335
Total assets	$	498,859	$	1,543,259		$	1,118,754		$	575,050		$	(2,671,523	)	$	1,064,399
LIABILITIES AND STOCKHOLDERS' AND MEMBER'S EQUITY
Current liabilities:
Current portion of long-term debt	$	—	$	—		$	139		$	—		$	—		$	139
Accounts payable-trade	—		1,097			23,748			39,324			—			64,169
Other payables and accruals	—		23,611			16,693			26,300			—			66,604
Deferred income taxes	—		—			—			1,549			—			1,549
Due to related party	—		—			—			15,396			—			15,396
Total current liabilities	—		24,708			40,580			82,569			—			147,857
Long-term debt, net of current portion	—		350,695			1,529			52,575			—			404,799
Deferred income taxes	—		11,255			—			1,438			—			12,693
Other long-term liabilities	—		658,704			95,528			96,487			(747,612		)	103,107
Total liabilities	—		1,045,362			137,637			233,069			(747,612		)	668,456
Commitments and contingencies (note 11)
Stockholders' and member's equity:
Preferred stock, $0.01 par value; 100,000 shares authorized; none issued	—		—			—			—			—			—
Common stock, $0.01 par value; 500,000 shares authorized	305		—			—			—			—			305
Additional paid in capital	347,462		—			—			—			—			347,462
Member's equity	—		498,859			1,050,324			374,728			(1,923,911		)	—
Retained earnings	151,092		—			—			—			—			151,092
Accumulated other comprehensive loss	—		(962		)	(69,207		)	(67,836		)	—			(138,005		)
Kraton stockholders' and member's equity	498,859		497,897			981,117			306,892			(1,923,911		)	360,854
Noncontrolling interest	—		—			—			35,089			—			35,089
Total stockholders' and member's equity	498,859		497,897			981,117			341,981			(1,923,911		)	395,943
Total liabilities and stockholders' and member's equity	$	498,859	$	1,543,259		$	1,118,754		$	575,050		$	(2,671,523	)	$	1,064,399

________________________________________________________

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

December 31, 2014

(In thousands, except par value)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	646		$	5,881		$	47,291		$	—		$	53,818
Receivables, net of allowances	—		553			37,266			69,613			—			107,432
Inventories of products	—		35			201,146			125,811			—			326,992
Inventories of materials and supplies	—		—			9,092			1,876			—			10,968
Deferred income taxes	—		—			3,566			3,681			—			7,247
Other current assets	—		5,317			931			18,273			—			24,521
Total current assets	—		6,551			257,882			266,545			—			530,978
Property, plant and equipment, less accumulated depreciation	—		46,081			248,220			157,464			—			451,765
Intangible assets, less accumulated amortization	—		45,356			4,000			254			—			49,610
Investment in consolidated subsidiaries	529,701		1,382,584			—			—			(1,912,285		)	—
Investment in unconsolidated joint venture	—		813			—			11,835			—			12,648
Debt issuance costs	—		4,674			1,297			1,182			—			7,153
Deferred income taxes	—		428			—			1,748			—			2,176
Other long-term assets	—		6,384			591,841			85,520			(655,623		)	28,122
Total assets	$	529,701	$	1,492,871		$	1,103,240		$	524,548		$	(2,567,908	)	$	1,082,452
LIABILITIES AND STOCKHOLDERS’ AND MEMBER’S EQUITY
Current liabilities:
Current portion of long-term debt	—		—			87			—			—			87
Accounts payable-trade	—		637			30,332			41,817			—			72,786
Other payables and accruals	—		21,913			14,017			14,958			—			50,888
Deferred income taxes	—		—			—			1,633			—			1,633
Due to related party	—		—			—			18,121			—			18,121
Total current liabilities	—		22,550			44,436			76,529			—			143,515
Long-term debt, net of current portion	—		350,825			960			—			—			351,785
Deferred income taxes	—		8,443			3,566			3,253			—			15,262
Other long-term liabilities	—		582,462			93,191			83,709			(655,623		)	103,739
Total liabilities	—		964,280			142,153			163,491			(655,623		)	614,301
Commitments and contingencies (note 11)
Stockholders’ and member’s equity:
Preferred stock, $.01 par value; 100,000 shares authorized; none issued	—		—			—			—			—			—
Common stock, $.01 par value; 500,000 shares authorized	318		—			—			—			—			318
Additional paid in capital	361,342		—			—			—			—			361,342
Member’s equity	—		529,701			1,030,294			352,290			(1,912,285		)	—
Retained earnings	168,041		—			—			—			—			168,041
Accumulated other comprehensive loss	—		(1,110		)	(69,207		)	(28,901		)	—			(99,218		)
Kraton stockholders’ and member’s equity	529,701		528,591			961,087			323,389			(1,912,285		)	430,483
Noncontrolling interest	—		—			—			37,668			—			37,668
Total stockholders’ and member’s equity	529,701		528,591			961,087			361,057			(1,912,285		)	468,151
Total liabilities and stockholders’ and member’s equity	$	529,701	$	1,492,871		$	1,103,240		$	524,548		$	(2,567,908	)	$	1,082,452

_____________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three Months Ended September 30, 2015

(Unaudited)

(In thousands)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenue	$	—	$	—		$	140,767	$	167,777		$	(39,532	)	$	269,012
Cost of goods sold	—		2,814			113,186		124,734			(39,532		)	201,202
Gross profit (loss)	—		(2,814		)	27,581		43,043			—			67,810
Operating expenses:
Research and development	—		1,713			1,128		4,756			—			7,597
Selling, general and administrative	—		3,445			7,639		15,833			—			26,917
Depreciation and amortization	—		5,652			7,882		2,611			—			16,145
Total operating expenses	—		10,810			16,649		23,200			—			50,659
Earnings in consolidated subsidiaries	8,019		27,684			—		—			(35,703		)	—
Earnings of unconsolidated joint venture	—		—			—		95			—			95
Interest expense (income), net	—		6,159			101		(109		)	—			6,151
Income before income taxes	8,019		7,901			10,831		20,047			(35,703		)	11,095
Income tax expense (benefit)	—		(118		)	—		3,194			—			3,076
Consolidated net income	8,019		8,019			10,831		16,853			(35,703		)	8,019
Net loss attributable to noncontrolling interest	—		—			—		(427		)	—			(427		)
Net income attributable to Kraton	$	8,019	$	8,019		$	10,831	$	17,280		$	(35,703	)	$	8,446

_________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three Months Ended September 30, 2014

(Unaudited)

(In thousands)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenue	$	—	$	—		$	154,297		$	205,428		$	(40,754	)	$	318,971
Cost of goods sold	—		(4,000		)	127,178			172,723			(40,754		)	255,147
Gross profit	—		4,000			27,119			32,705			—			63,824
Operating expenses:
Research and development	—		3,566			821			3,053			—			7,440
Selling, general and administrative	—		8,741			137			7,496			—			16,374
Depreciation and amortization	—		5,746			7,390			3,416			—			16,552
Total operating expenses	—		18,053			8,348			13,965			—			40,366
Earnings in consolidated subsidiaries	16,317		35,993			—			—			(52,310		)	—
Earnings of unconsolidated joint venture	—		—			—			80			—			80
Interest expense (income), net	—		6,183			(85		)	1			—			6,099
Income before income taxes	16,317		15,757			18,856			18,819			(52,310		)	17,439
Income tax expense (benefit)	—		(560		)	196			1,486			—			1,122
Consolidated net income	16,317		16,317			18,660			17,333			(52,310		)	16,317
Net loss attributable to noncontrolling interest	—		—			—			(298		)	—			(298		)
Net income attributable to Kraton	$	16,317	$	16,317		$	18,660		$	17,631		$	(52,310	)	$	16,615

_________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Nine Months Ended September 30, 2015

(Unaudited)

(In thousands)



	KPPI			Kraton Polymers LLC (1)			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenue	$	—		$	—		$	426,787		$	489,124		$	(129,562	)	$	786,349
Cost of goods sold	—			13,680			352,599			387,825			(129,562		)	624,542
Gross profit (loss)	—			(13,680		)	74,188			101,299			—			161,807
Operating expenses (income):
Research and development	—			2,906			2,993			17,446			—			23,345
Selling, general and administrative	—			(3,090		)	30,200			50,378			—			77,488
Depreciation and amortization	—			16,897			21,863			8,092			—			46,852
Total operating expenses	—			16,713			55,056			75,916			—			147,685
Earnings (loss) in consolidated subsidiaries	(7,715		)	41,329			—			—			(33,614		)	—
Earnings of unconsolidated joint venture	—			—			—			273			—			273
Interest expense (income), net	—			18,581			(372		)	(234		)	—			17,975
Income (loss) before income taxes	(7,715		)	(7,645		)	19,504			25,890			(33,614		)	(3,580		)
Income tax expense (benefit)	—			70			(527		)	4,592			—			4,135
Consolidated net income (loss)	(7,715		)	(7,715		)	20,031			21,298			(33,614		)	(7,715		)
Net loss attributable to noncontrolling interest	—			—			—			(1,141		)	—			(1,141		)
Net income (loss) attributable to Kraton	$	(7,715	)	$	(7,715	)	$	20,031		$	22,439		$	(33,614	)	$	(6,574	)

_________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Nine Months Ended September 30, 2014

(Unaudited)

(In thousands)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenue	$	—	$	—		$	485,368	$	596,210		$	(127,184	)	$	954,394
Cost of goods sold	—		(19,414		)	391,743		516,272			(127,184		)	761,417
Gross profit	—		19,414			93,625		79,938			—			192,977
Operating expenses:
Research and development	—		12,115			1,758		9,863			—			23,736
Selling, general and administrative	—		55,208			262		23,402			—			78,872
Depreciation and amortization	—		16,870			21,912		10,848			—			49,630
Total operating expenses	—		84,193			23,932		44,113			—			152,238
Earnings in consolidated subsidiaries	18,991		100,871			—		—			(119,862		)	—
Earnings of unconsolidated joint venture	—		—			—		324			—			324
Interest expense (income), net	—		18,661			79		(73		)	—			18,667
Income before income taxes	18,991		17,431			69,614		36,222			(119,862		)	22,396
Income tax expense (benefit)	—		(1,560		)	201		4,764			—			3,405
Consolidated net income	18,991		18,991			69,413		31,458			(119,862		)	18,991
Net loss attributable to noncontrolling interest	—		—			—		(858		)	—			(858		)
Net income attributable to Kraton	$	18,991	$	18,991		$	69,413	$	32,316		$	(119,862	)	$	19,849

_________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three Months Ended September 30, 2015

(Unaudited)

(In thousands)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net income attributable to Kraton	$	8,019	$	8,019		$	10,831	$	17,280		$	(35,703	)	$	8,446
Other comprehensive loss:
Foreign currency translation adjustments, net of tax of $0	—		(75		)	—		(14,897		)	—			(14,972		)
Other comprehensive loss, net of tax	—		(75		)	—		(14,897		)	—			(14,972		)
Comprehensive income attributable to Kraton	8,019		7,944			10,831		2,383			(35,703		)	(6,526		)
Comprehensive loss attributable to noncontrolling interest	—		—			—		(2,717		)	—			(2,717		)
Consolidated comprehensive income (loss)	$	8,019	$	7,944		$	10,831	$	(334	)	$	(35,703	)	$	(9,243	)

_________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three Months Ended September 30, 2014

(Unaudited)

(In thousands)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net income attributable to Kraton	$	16,317	$	16,317		$	18,660	$	17,631		$	(52,310	)	$	16,615
Other comprehensive loss:
Foreign currency translation adjustments, net of tax	—		(264		)	—		(28,323		)	—			(28,587		)
Other comprehensive loss, net of tax	—		(264		)	—		(28,323		)	—			(28,587		)
Comprehensive income (loss) attributable to Kraton	16,317		16,053			18,660		(10,692		)	(52,310		)	(11,972		)
Comprehensive loss attributable to noncontrolling interest	—		—			—		(1,092		)	—			(1,092		)
Consolidated comprehensive income (loss)	$	16,317	$	16,053		$	18,660	$	(11,784	)	$	(52,310	)	$	(13,064	)

__________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Nine Months Ended September 30, 2015

(Unaudited)

(In thousands)



	KPPI			Kraton Polymers LLC (1)			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net income (loss) attributable to Kraton	$	(7,715	)	$	(7,715	)	$	20,031	$	22,439		$	(33,614	)	$	(6,574	)
Other comprehensive income (loss):
Foreign currency translation adjustments, net of tax of $0	—			148			—		(38,935		)	—			(38,787		)
Other comprehensive income (loss), net of tax	—			148			—		(38,935		)	—			(38,787		)
Comprehensive income (loss) attributable to Kraton	(7,715		)	(7,567		)	20,031		(16,496		)	(33,614		)	(45,361		)
Comprehensive loss attributable to noncontrolling interest	—			—			—		(2,579		)	—			(2,579		)
Consolidated comprehensive income (loss)	$	(7,715	)	$	(7,567	)	$	20,031	$	(19,075	)	$	(33,614	)	$	(47,940	)

_________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Nine Months Ended September 30, 2014

(Unaudited)

(In thousands)



	KPPI		Kraton Polymers LLC (1)			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net income attributable to Kraton	$	18,991	$	18,991		$	69,413	$	32,316		$	(119,862	)	$	19,849
Other comprehensive loss:
Foreign currency translation adjustments, net of tax	—		(532		)	—		(25,119		)	—			(25,651		)
Other comprehensive loss, net of tax	—		(532		)	—		(25,119		)	—			(25,651		)
Comprehensive income (loss) attributable to Kraton	18,991		18,459			69,413		7,197			(119,862		)	(5,802		)
Comprehensive loss attributable to noncontrolling interest	—		—			—		(1,479		)	—			(1,479		)
Consolidated comprehensive income (loss)	$	18,991	$	18,459		$	69,413	$	5,718		$	(119,862	)	$	(7,281	)

__________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Nine Months Ended September 30, 2015

(Unaudited)

(In thousands)



	KPPI			Kraton Polymers LLC (1)			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows provided by (used in) operating activities	$	—		$	(16,074	)	$	73,706		$	23,941		$	—		$	81,573
Cash flows used in investing activities:
Proceeds from intercompany loans	—			48,927			—			—			(48,927		)	—
Kraton purchase of property, plant and equipment	—			(913		)	(29,257		)	(12,214		)	—			(42,384		)
KFPC purchase of property, plant and equipment	—			—			—			(46,097		)	—			(46,097		)
Purchase of software and other intangibles	—			(1,717		)	(46		)	—			—			(1,763		)
Net cash used in investing activities	—			46,297			(29,303		)	(58,311		)	(48,927		)	(90,244		)
Cash flows provided by (used in) financing activities:
Proceeds from debt	—			—			30,000			—			—			30,000
Repayments of debt	—			—			(30,000		)	—			—			(30,000		)
KFPC proceeds from debt	—			—			—			55,622			—			55,622
Capital lease payments	—			—			(99		)	—			—			(99		)
Purchase of treasury stock	(31,891		)	—			—			—			—			(31,891		)
Cash contributions from member	—			(31,891		)	—			—			31,891			—
Cash distributions to member	30,869			1,022			—			—			(31,891		)	—
Proceeds from the exercise of stock options	1,022			—			—			—			—			1,022
Payments on intercompany loans	—			—			(48,927		)	—			48,927			—
Net cash provided by (used in) financing activities	—			(30,869		)	(49,026		)	55,622			48,927			24,654
Effect of exchange rate differences on cash	—			—			—			(6,002		)	—			(6,002		)
Net increase (decrease) in cash and cash equivalents	—			(646		)	(4,623		)	15,250			—			9,981
Cash and cash equivalents, beginning of period	—			646			5,881			47,291			—			53,818
Cash and cash equivalents, end of period	$	—		$	—		$	1,258		$	62,541		$	—		$	63,799

__________________________________________

(1)

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Nine Months Ended September 30, 2014

(Unaudited)

(In thousands)



	KPPI			Kraton Polymers LLC (1)			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows provided by (used in) operating activities	$	—		$	(25,208	)	$	64,822		$	(58,391	)	$	—		$	(18,777	)
Cash flows provided by (used in) investing activities:
Proceeds from intercompany loans	—			27,679			—			—			(27,679		)	—
Kraton purchase of property, plant and equipment	—			(725		)	(36,513		)	(10,301		)	—			(47,539		)
KFPC purchase of property, plant and equipment	—			—			—			(33,807		)	—			(33,807		)
Purchase of software and other intangibles	—			(2,724		)	—			—			—			(2,724		)
Net cash provided by (used in) investing activities	—			24,230			(36,513		)	(44,108		)	(27,679		)	(84,070		)
Cash flows provided by (used in) financing activities:
Proceeds from debt	—			—			29,000			—			—			29,000
Repayments of debt	—			—			(29,000		)	—			—			(29,000		)
Capital lease payments	—			—			(6,007		)	—			—			(6,007		)
Purchase of treasury stock	(704		)	—			—			—			—			(704		)
Cash contributions from member	—			—			(704		)	—			704			—
Cash distributions to member	(725		)	1,429			—			—			(704		)	—
Proceeds from the exercise of stock options	1,429			—			—			—			—			1,429
Debt issuance costs				(24		)				(461		)				(485		)
Payments on intercompany loans	—			—			(27,679		)	—			27,679			—
Net cash provided by (used in) financing activities	—			1,405			(34,390		)	(461		)	27,679			(5,767		)
Effect of exchange rate differences on cash	—			—			—			(4,971		)	—			(4,971		)
Net increase (decrease) in cash and cash equivalents	—			427			(6,081		)	(107,931		)	—			(113,585		)
Cash and cash equivalents, beginning of period	—			—			11,792			164,080			—			175,872
Cash and cash equivalents, end of period	$	—		$	427		$	5,711		$	56,149		$	—		$	62,287

___________________________________

(1)


Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.

INTRODUCTION

You should read the following discussion of our financial condition and results of operations with our audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K as of and for the year ended December 31, 2014. This discussion contains forward-looking statements and involves numerous risks, assumptions and uncertainties, including, but not limited to, the risk factors discussed in the “Risk Factors” section of our most recent Form 10-K, as well as in “Factors Affecting Our Results of Operations,” “Risk Factors” and elsewhere in this Form 10-Q. Actual results may differ materially from those contained in any forward-looking statements.

OVERVIEW

We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized over 50 years ago, that enhance the performance of numerous products by imparting greater flexibility, resilience, strength, durability and processability.

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins than more commoditized products. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products, such as disposable diapers, and in the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex^TM isoprene rubber and isoprene rubber latex. Our Cariflex products are based on synthetic polyisoprene polymer and do not contain natural rubber latex or other natural rubber products making them an ideal substitute for natural rubber latex, particularly in applications with high purity requirements such as medical, healthcare, personal care and food contact. We believe the versatility of Cariflex provides opportunities for new, differentiated applications.

We have a portfolio of innovations at various stages of development and commercialization, including


•	polyvinyl chloride alternatives for wire and cable, and medical applications;


•	polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;


•	highly-modified asphalt (“HiMA”) for high-performance paving applications;


•	high melt flow polymers for compounding and adhesives formulation;


•	NEXAR^TM polymers for heating, ventilation, air conditioning and breathable fabrics; and


•	synthetic cement formulations and polymers used for viscosity modification in oilfield applications.

The majority of worldwide SBC production is dedicated to un-hydrogenated SBCs (“USBCs”), which are primarily used in paving, roofing, adhesives, sealants, coatings, and footwear applications. Hydrogenated SBCs (“HSBCs”), which are significantly more complex and capital-intensive to manufacture than USBCs, are used in applications such as soft touch and flexible materials, personal hygiene products, medical products, automotive components and certain adhesives and sealant applications. Isoprene rubber (“IR”) and isoprene rubber latex (“IRL”) are non-SBC products which are primarily used in applications such as medical products, personal care, adhesives, tackifiers, paints and coatings.

Our products are manufactured and our commercial activities are organized in the following product groups based upon polymer chemistry and process technologies:



	Three Months Ended September 30,				Nine Months Ended September 30,
Product Group Revenue Percentage:	2015		2014		2015		2014
Performance Products	55.0	%	56.5	%	53.5	%	55.7	%
Specialty Polymers	32.3	%	31.0	%	33.5	%	33.3	%
Cariflex	12.7	%	12.5	%	13.0	%	11.0	%

2015 Third Quarter Financial Overview


•	Sales volume was 81.0 kilotons in the third quarter of 2015 compared to 80.7 kilotons in the third quarter of 2014.


•	Revenue was $269.0 million in the third quarter of 2015 compared to $319.0 million in the third quarter of 2014.


•	Gross profit was $67.8 million in the third quarter of 2015 compared to $63.8 million in the third quarter of 2014. Adjusted gross profit (non-GAAP) was $68.8 million in the third quarter of 2015 compared to $64.8 million in the third quarter of 2014.


•	Adjusted EBITDA (non-GAAP) was $42.4 million in the third quarter of 2015 compared to $39.4 million in the third quarter of 2014.


•	Net income attributable to Kraton was $8.4 million, or $0.27 per diluted share, in the third quarter of 2015 compared to $16.6 million, or $0.50 per diluted share, in the third quarter of 2014.


•	Adjusted diluted earnings per share (non-GAAP) was $0.48 per share in the third quarter of 2015 compared to $0.35 per share in the third quarter of 2014.


•	For the third quarter of 2015 compared to the third quarter of 2014, foreign currency fluctuations had a negative impact on adjusted gross profit and adjusted EBITDA of $2.4 million and $1.0 million, respectively.

RESULTS OF OPERATIONS

Factors Affecting Our Results of Operations

Raw Materials. We use butadiene, styrene and isoprene as our primary raw materials in manufacturing our products, and our results of operations are directly affected by the cost of these raw materials. On a FIFO basis, these monomers together represented approximately $94.1 million and $135.1 million, or 46.8% and 53.0%, of our total cost of goods sold for the three months ended September 30, 2015 and 2014, respectively, and approximately $297.7 million and $393.7 million or 47.7% and 51.7% of our total cost of goods sold for the nine months ended September 30, 2015 and 2014, respectively. Since the cost of our three primary raw materials comprise a significant amount of our total cost of goods sold, our selling prices for our products and therefore our total revenue are impacted by movements in our raw material costs, as well as the cost of other inputs.

The cost of these monomers has generally correlated with changes in energy prices and is generally influenced by supply and demand factors, and prices for natural and synthetic rubber. Average purchase prices for each of these monomers decreased during the three and nine months ended September 30, 2015 compared to the three and nine months ended September 30, 2014.

We use the first-in, first-out (FIFO) basis of accounting for inventory and cost of goods sold and therefore gross profit. In periods of raw material price volatility, reported results under FIFO will differ from what the results would have been if cost of goods sold were based on estimated current replacement cost (“ECRC”). Specifically, in periods of rising raw material costs, reported gross profit will be higher under FIFO than under ECRC. Conversely, in periods of declining raw material costs, reported gross profit will be lower under FIFO than under ECRC. In recognition of the fact that the cost of raw materials affects our results of operations and the comparability of our results of operations, we provide the spread between FIFO and ECRC.


•	In the three and nine months ended September 30, 2015, reported results under FIFO were lower than results would have been on an ECRC basis by $0.9 million and $40.1 million, respectively; and


•	In the three months ended September 30, 2014, reported results under FIFO were lower than results would have been on an ECRC basis by $1.8 million; and


•	In the nine months ended September 30, 2014, reported results under FIFO were higher than results would have been on an ECRC basis by $6.5 million.

International Operations and Currency Fluctuations. We operate a geographically diverse business, serving customers in over 60 countries from five manufacturing facilities on four continents. Our sales and production costs are mainly denominated in U.S. dollars, Euro, Japanese Yen and Brazilian Real. From time to time, we use hedging strategies to reduce our exposure to currency fluctuations.

We generated our revenue from customers located in the following regions:



	Three Months Ended September 30,				Nine Months Ended September 30,
Revenue by Geography:	2015		2014		2015		2014
Americas	38.8	%	37.7	%	39.0	%	39.4	%
Europe, Middle East and Africa	34.1	%	37.0	%	33.5	%	36.9	%
Asia Pacific	27.1	%	25.3	%	27.5	%	23.7	%

Our financial results are subject to gains and losses on currency translations, which occur when the financial statements of our foreign operations are translated into U.S. dollars. The financial statements of operations outside the United States where the local currency is considered to be the functional currency are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and the average exchange rate for each period for revenues, expenses, gains and losses and cash flows. The effect of translating the balance sheet into U.S. dollars is included as a component of accumulated other comprehensive income (loss). Any appreciation of the functional currencies against the U.S. dollar will increase the U.S. dollar equivalent amounts of revenues, expenses, gains and losses and cash flows, and any depreciation of the functional currencies will decrease the U.S. dollar amounts reported. Our results of operations are also subject to currency transaction risk. We incur currency transaction risk when we enter into either a purchase or sale transaction using a currency other than the local currency of the transacting entity. The estimated impact from currency fluctuations amounted to pre-tax losses of $0.7 million and $1.0 million for the three months ended September 30, 2015 and 2014, respectively, and pre-tax losses of $4.6 million and $2.5 million for the nine months ended September 30, 2015 and 2014, respectively. The primary driver for the increase in our pre-tax currency losses for the nine months ended September 30, 2015 compared to the nine months ended September 30, 2014 was the change in foreign exchange rates between the Euro and U.S. Dollar.

Seasonality. Seasonal changes and weather conditions typically affect our Performance Products sales into paving and roofing applications, which generally results in higher sales volumes in the second and third quarters of the calendar year compared to the first and fourth quarters of the calendar year. Our other markets tend to show relatively little seasonality.

Recent Developments

Agreement Signed to Acquire Arizona Chemical Holdings Corporation. On September 27, 2015, Kraton Polymers LLC, one of our wholly owned subsidiaries, entered into a stock purchase agreement with Arizona Chemical, a leading global producer of high-value performance products and specialty chemicals derived from renewable raw materials, and AZC Holding Company LLC, the sole stockholder of Arizona Chemical. Pursuant to the stock purchase agreement, we agreed to acquire all of the outstanding capital stock of Arizona Chemical for a cash purchase price of $1,370.0 million, subject to adjustment for cash and indebtedness at closing, as well as an adjustment for working capital and other items. The Arizona Chemical Acquisition is expected to close in late 2015 or early 2016, subject to certain customary closing conditions and the clearances and approvals under the rules of antitrust and competition law authorities in the United States, Germany, Russia and the Ukraine. See “Part II, Item 1A. Risk Factors” for discussion of certain risks and uncertainties related to the Arizona Chemical Acquisition.

Outlook

We currently estimate that our results in the fourth quarter of 2015 will reflect a negative spread between FIFO and ECRC of approximately $10.0 million. We believe the current raw material price environment is positive for our business, as lower average selling prices, in combination with the performance qualities of Kraton's product offering, provide a strong value proposition relative to competing materials.

Three Months Ended September 30, 2015 Compared to Three Months Ended September 30, 2014

Revenue

Revenue was $269.0 million for the three months ended September 30, 2015 compared to $319.0 million for the three months ended September 30, 2014, a decrease of $50.0 million or 15.7%. Excluding the $23.9 million negative effect from currency movements, revenue declined $26.0 million, or 8.2%, attributable to lower average selling prices resulting from lower raw material costs. Sales volumes were 81.0 kilotons for the third quarter of 2015 compared to 80.7 kilotons for the third quarter of 2014.

With respect to revenue for each of our product groups:

•

Cariflex™ revenue was $34.0 million for the three months ended September 30, 2015 compared to $40.0 million for the three months ended September 30, 2014, a decline of $5.9 million, or 14.8%. The negative effect of currency fluctuations accounted for $2.1 million of the decline. The remaining $3.8 million, or 9.6%, of the decline was primarily due to lower sales volume. Sales volume decreased compared to record sales volume for this product group in the third quarter of 2014 primarily due to lower sales into surgical glove applications associated with variability in customer order patterns which are typical in the Cariflex product group.

•

Specialty Polymers revenue was $86.8 million for the three months ended September 30, 2015 compared to $98.7 million for the three months ended September 30, 2014. Of the $11.9 million, or 12.1%, revenue decline, $4.7 million is associated with the negative effect of currency fluctuations, and the balance of the decline is primarily due to lower average selling prices resulting from lower raw material costs. Compared to the third quarter of 2014, sales volumes increased modestly due to growth in industrial, consumer, and cable gel applications partially offset by lower volumes into lubricant additives.

•

Performance Products revenue was $148.0 million for the three months ended September 30, 2015 compared to $180.1 million for the three months ended September 30, 2014. Of the $32.1 million, or 17.8%, revenue decline,$17.1 million is associated with the negative effect of currency fluctuations, and the balance of the decline is primarily due to lower average selling prices resulting from lower raw material costs. With respect to sales volume, we experienced strong demand for our paving applications, largely in North America, where we experienced share gains and higher sales of differentiated grades. These sales volume gains were offset by lower sales into roofing applications in Europe and lower sales into less differentiated pressure sensitive and construction adhesive applications.

Cost of Goods Sold

Cost of goods sold was $201.2 million for the three months ended September 30, 2015 compared to $255.1 million for the three months ended September 30, 2014. The $53.9 million, or 21.1%, decrease was primarily driven by a $32.0 million reduction in raw material costs, and a $21.4 million positive effect from currency fluctuations. In addition, cost of goods sold decreased $3.7 million associated with cost reduction initiatives and $1.6 million due to lower turnaround costs partially offset by a $1.4 million increase related to modestly higher sales volumes.

Gross Profit

Gross profit was $67.8 million for the three months ended September 30, 2015 compared to $63.8 million for the three months ended September 30, 2014. Gross profit as a percentage of revenue was 25.2% and 20.0% for the three months ended September 30, 2015 and 2014, respectively.

Operating Expenses

Research and development expenses were $7.6 million for the three months ended September 30, 2015 compared to $7.4 million for the three months ended September 30, 2014, an increase of $0.2 million, or 2.1%.

Selling, general and administrative expenses were $26.9 million for the three months ended September 30, 2015 compared to $16.4 million for the three months ended September 30, 2014, an increase of $10.5 million, or 64.4%. This increase was primarily due to $5.0 million of transaction and acquisition related costs incurred in the third quarter 2015, a $4.2 million reduction in the accrual for fees related to the terminated Combination Agreement with LCY in the third quarter 2014, and a $2.9 million increase in variable employee compensation costs. These increases were partially offset by a $1.0 million positive effect from currency fluctuations and a $1.0 million decrease associated with cost reduction initiatives.

Depreciation and amortization was $16.1 million for the three months ended September 30, 2015 compared to $16.6 million for the three months ended September 30, 2014, a decrease of $0.4 million or 2.5%, primarily due to a $0.7 million positive effect from currency fluctuations.

Interest expense, net

Interest expense, net was $6.2 million for the three months ended September 30, 2015 compared to $6.1 million for the three months ended September 30, 2014, an increase of $0.1 million or 0.9%.

Income tax expense

Income tax expense was $3.1 million and $1.1 million for the three months ended September 30, 2015 and 2014, respectively. Our effective tax rate was 27.7% and 6.4% for the three months ended September 30, 2015 and 2014, respectively. Our effective tax rate differed from the U.S. corporate statutory tax rate of 35.0% primarily due to the mix of pre-tax income or loss earned in foreign jurisdictions and losses generated in the U.S. tax jurisdiction for which a full valuation allowance has been provided. See Note 10 Income Taxes, for further information.

Net income attributable to Kraton

Net income attributable to Kraton was $8.4 million or $0.27 per diluted share for the three months ended September 30, 2015, a decrease of $8.2 million compared to net income of $16.6 million or $0.50 per diluted share for the three months ended September 30, 2014. Net income for the three months ended September 30, 2015 was negatively impacted by the following items, net of tax:


•	Transaction and acquisition related costs of $4.9 million or $0.16 per diluted share


•	Negative spread between FIFO and ECRC of $1.0 million or $0.03 per diluted share


•	Restructuring and other charges of $0.5 million or $0.02 per diluted share


•	Start-up charges related to the KFPC joint venture of $0.3 million or $0.01 per diluted share

Net income for the three months ended September 30, 2014 was positively impacted by the following items, net of tax:


•	A reduction in the accrual for fees related to the terminated Combination Agreement with LCY of $4.2 million or $0.13 per diluted share


•	A reduction in our income tax valuation allowance of $1.9 million or $0.06 per diluted share related to the assessment of our ability to utilize net operating losses in future periods


•	An insurance recovery related to the production downtime at our Belpre, Ohio facility of $1.0 million or $0.03 per diluted share

In addition, net income for the three months ended September 30, 2014 was negatively impacted by the following items, net of tax:


•	Negative spread between FIFO and ECRC of $1.8 million or $0.06 per diluted share


•	Start-up charges related to the joint venture with FPCC of $0.2 million or $0.01 per diluted share

Nine Months Ended September 30, 2015 Compared to Nine Months Ended September 30, 2014

Revenue

Revenue was $786.3 million for the nine months ended September 30, 2015 compared to $954.4 million for the nine months ended September 30, 2014, a decrease of $168.0 million or 17.6%. The negative effect from currency movements accounted for $72.7 million of the decrease. The remaining $95.3 million, or 10.0%, decline was due to lower average selling prices amounting to $86.3 million driven by lower average raw material costs and $9.0 million due to lower sales volumes. Sales volumes were 231.6 kilotons for the nine months ended September 30, 2015, a decrease of 1.8 kilotons compared to the nine months ended September 30, 2014.

With respect to revenue for each of our product groups:

•

Cariflex™ revenue was $102.1 million for the nine months ended September 30, 2015 compared to $104.6 million for the nine months ended September 30, 2014, a decrease of $2.5 million or 2.4%. Cariflex sales volumes increased 5.2% compared to the nine months ended September 30, 2014, driven primarily by higher sales into surgical glove applications. The $6.1 million positive impact on revenue from higher sales volume was more than offset by a $6.6 million negative effect from currency fluctuations and a decline of $2.0 million associated with lower selling prices resulting from lower isoprene costs. Excluding the negative impact from currency fluctuations, revenue would have increased $4.1 million, or 3.9%.

•

Specialty Polymers revenue was $263.1 million for the nine months ended September 30, 2015 compared to $317.6 million for the nine months ended September 30, 2014. Of the $54.5 million, or 17.2%, revenue decrease, $15.9 million was associated with the negative effect of currency fluctuations. The balance of the decline was due to lower average selling prices resulting from lower raw material costs and a 5.5% decrease in sales volumes. The decrease in sales volume was largely due to lower sales into lubricant additive applications associated with inventory reduction measures by a significant customer, and, to a lesser extent, lower sales into personal care applications. Partially offsetting these declines were higher sales into industrial, medical, and cable gel applications.

•

Performance Products revenue was $420.9 million for the nine months ended September 30, 2015 compared to $531.9 million for the nine months ended September 30, 2014. Of the $111.1 million, or 20.9%, revenue decrease, $50.2 million was associated with the negative effect of currency fluctuations, and the balance of the decline was primarily due to lower average selling prices resulting from lower raw material costs. Sales volume increased modestly, despite the previously disclosed seven kilotons of lost production at our Wesseling and Berre facilities in the second quarter 2015. The net increase in sales volume was driven by higher sales into paving applications in North America and personal care applications, largely offset by lower sales into roofing applications in Europe and adhesives applications.

Cost of Goods Sold

Cost of goods sold was $624.5 million for the nine months ended September 30, 2015 compared to $761.4 million for the nine months ended September 30, 2014. The $136.9 million, or 18.0%, decrease was largely driven by a $63.4 million positive effect from currency fluctuations, a $65.1 million reduction in raw material costs, a $7.1 million decrease due to lower sales volumes, and a $7.5 million decrease related to cost reduction initiatives. In addition, cost of goods sold decreased by $11.9 million due to the absence of the weather-related production downtime at our Belpre, Ohio, facility and an operating disruption from a small fire at our Berre, France, facility that occurred in the first quarter of 2014. These decreases were partially offset by $5.0 million of higher turnaround costs primarily driven by a statutory six-year turnaround at our Berre, France, facility, $2.5 million of higher costs related to an inventory write-down resulting from an operational issue at our Belpre, Ohio, facility and $10.6 million of higher other manufacturing costs that are primarily timing related.

Gross Profit

Gross profit was $161.8 million for the nine months ended September 30, 2015 compared to $193.0 million for the nine months ended September 30, 2014. Gross profit as a percentage of revenue was 20.6% and 20.2% for the nine months ended September 30, 2015 and 2014, respectively.

Operating Expenses

Research and development expenses were $23.3 million for the nine months ended September 30, 2015 compared to $23.7 million for the nine months ended September 30, 2014, a decrease of $0.4 million, or 1.6%. This decrease was primarily driven by a $1.4 million positive effect from currency fluctuations, and a $1.3 million decrease related to cost reduction initiatives. These decreases were partially offset by a $1.2 million increase in variable employee compensation and $0.8 million of higher costs associated with the new semi-works facility.

Selling, general and administrative expenses were $77.5 million for the nine months ended September 30, 2015 compared to $78.9 million for the nine months ended September 30, 2014, a decrease of $1.4 million or 1.8%. This decrease was primarily due to a $3.0 million positive effect from currency fluctuations, a $3.0 million reduction in transaction and acquisition related costs, a $3.1 million decrease from cost reduction initiatives, and $0.9 million of lower marketing costs. These decreases were partially offset by a $5.9 million increase in employee related costs, primarily variable compensation, and a $2.3 million increase in professional fees.

Depreciation and amortization was $46.9 million for the nine months ended September 30, 2015 compared to $49.6 million for the nine months ended September 30, 2014, a decrease of $2.8 million or 5.6%, primarily due to a $1.9 million positive effect from currency fluctuations.

Interest expense, net

Interest expense, net was $18.0 million for the nine months ended September 30, 2015 compared to $18.7 million for the nine months ended September 30, 2014, a decrease of $0.7 million or 3.7%. The decrease is primarily due to higher capitalized interest related to ongoing capital projects in the nine months ended September 30, 2015 compared with the nine months ended September 30, 2014.

Income tax expense

Income tax expense was $4.1 million and $3.4 million for the nine months ended September 30, 2015 and 2014, respectively. Our effective tax rate was (115.5)% and 15.2% for the nine months ended September 30, 2015 and 2014, respectively. Our effective tax rate differed from the U.S. corporate statutory tax rate of 35.0% primarily due to the mix of pre-tax income or loss earned in foreign jurisdictions and losses generated in the U.S. tax jurisdiction for which a full valuation allowance has been provided, as well as permanent differences, uncertain tax positions and return to provision adjustments. See Note 10 Income Taxes, for further information.

Net income (loss) attributable to Kraton

Net loss attributable to Kraton was $6.6 million or $0.21 per diluted share for the nine months ended September 30, 2015, a decrease of $26.4 million compared to net income of $19.8 million or $0.60 per diluted share for the nine months ended September 30, 2014. Net loss for the nine months ended September 30, 2015 was negatively impacted by the following items, net of tax:


•	Negative spread between FIFO and ECRC of $38.9 million or $1.23 per diluted share


•	Turnaround activity and unplanned production issues of $13.2 million or $0.42 per diluted share


•	Transaction and acquisition related costs of $5.7 million or $0.18 per diluted share


•	Restructuring and other charges of $1.4 million or $0.05 per diluted share


•	Start-up charges related to the KFPC joint venture of $0.8 million or $0.02 per diluted share

In addition, net loss for the nine months ended September 30, 2015 was positively impacted by the following item, net of tax:


•	An additional insurance recovery related to the first quarter 2014 Belpre production downtime of $0.3 million or $0.01 per diluted share.

Net income for the nine months ended September 30, 2014 was negatively impacted by the following items, net of tax:


•	Production downtime at our Belpre, Ohio and Berre, France facilities of $12.0 million, net of a $1.0 million insurance recovery, or $0.36 per diluted share


•	Fees related to the terminated Combination Agreement with LCY of $8.8 million or $0.27 per diluted share


•	Start-up charges related to the KFPC joint venture of $0.6 million or $0.02 per diluted share


•	Restructuring and other charges of $0.5 million or $0.02 per diluted share

In addition, net income for the nine months ended September 30, 2014 was positively impacted by the following items, net of tax:


•	Positive spread between FIFO and ECRC of $6.4 million or $0.19 per diluted share


•	A reduction in our income tax valuation allowance of $1.9 million or $0.06 per diluted share related to the assessment of our ability to utilize net operating losses in future periods

Critical Accounting Policies

For a discussion of our critical accounting policies and estimates that require the use of significant estimates and judgments, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2014.

Adjusted Gross Profit, EBITDA, Adjusted EBITDA, and Adjusted Diluted Earnings Per Share

We consider Adjusted Gross Profit, EBITDA, Adjusted EBITDA and Adjusted Diluted Earnings Per Share to be important supplemental measures of our performance and believe they are frequently used by investors, securities analysts and other interested parties in the evaluation of our performance and/or that of other companies in our industry, including period-to-period comparisons. In addition, management uses these measures to evaluate operating performance, and our incentive compensation plan bases incentive compensation payments on our Adjusted EBITDA performance, along with other factors. Adjusted Gross Profit, EBITDA, Adjusted EBITDA and Adjusted Diluted Earnings Per Share have limitations as analytical tools and in some cases can vary substantially from other measures of our performance. You should not consider any of them in isolation, or as substitutes for analysis of our results under U.S. generally accepted accounting principles (“GAAP”).



	Three months ended September 30,				Nine months ended September 30,
	2015		2014		2015		2014
	(In thousands, except per share amounts)
Adjusted Gross Profit (1) (2)	$	68,773	$	64,786	$	202,015	$	198,958
EBITDA (3)	$	33,391	$	40,090	$	61,247	$	90,693
Adjusted EBITDA (1) (4)	$	42,393	$	39,417	$	116,773	$	115,491
Adjusted Diluted Earnings Per Share (1) (2)	$	0.48	$	0.35	$	1.26	$	1.01

____________________________________________________

(1)

Although we report our financial results using the FIFO basis of accounting, as part of our pricing strategy, we measure our business performance using the ECRC of our inventory and cost of goods sold. We maintain our perpetual inventory in our global enterprise resource planning system, where the carrying value of our inventory is determined using FIFO. At the beginning of each month, we determine the estimated current cost of our raw materials for that particular month, and using the same perpetual inventory system that we use to manage inventory and therefore costs of goods sold under FIFO, we revalue our ending inventory to reflect the total cost of such inventory as if it was valued using the ECRC. The result of this revaluation from FIFO creates the spread between FIFO and ECRC. With inventory valued under FIFO and ECRC, we then have the ability to report cost of goods sold and therefore Adjusted Gross Profit, Adjusted EBITDA, and Adjusted Diluted Earnings Per Share under both our FIFO convention and ECRC.

(2)

Adjusted Gross Profit is gross profit net of the impact of the spread between the FIFO basis of accounting and ECRC and net of the impact of items we do not consider indicative of our ongoing operating performance. Similarly, Adjusted Diluted Earnings Per Share is diluted earnings per share net of the impact of the spread between the FIFO basis of accounting and ECRC and net of the impact of items we do not consider indicative of our ongoing operating performance. We explain how each adjustment is derived and why we believe it is helpful and appropriate in the reconciliations below. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. As a measure of our performance, Adjusted Gross Profit and Adjusted Diluted Earnings Per Share are limited because they often vary substantially from gross profit and diluted earnings per share calculated in accordance with US GAAP.


(3)	EBITDA represents net income before interest, taxes, depreciation and amortization. Limitations for EBITDA as an analytical tool include the following:


•	EBITDA does not reflect the significant interest expense on our debt;


•	EBITDA does not reflect the significant depreciation and amortization expense associated with our long-lived assets;

•

EBITDA included herein should not be used for purposes of assessing compliance or non-compliance with financial covenants under our debt agreements. The calculation of EBITDA in the debt agreements includes adjustments, such as extraordinary, non-recurring or one-time charges, proforma cost savings, certain non-cash items, turnaround costs, and other items included in the definition of EBITDA in the debt agreements; and


•	other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure.

(4)

Adjusted EBITDA is EBITDA net of the impact of the spread between the FIFO basis of accounting and ECRC and net of the impact of items we do not consider indicative of our ongoing operating performance. We explain how each adjustment is derived and why we believe it is helpful and appropriate in the reconciliation below. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. As an analytical tool, Adjusted EBITDA is subject to the limitations applicable to EBITDA described above, as well as the following limitations:


•	due to volatility in raw material prices, Adjusted EBITDA may, and often does, vary substantially from EBITDA, net income and other performance measures, including net income calculated in accordance with US GAAP; and


•	Adjusted EBITDA may, and often will, vary significantly from EBITDA calculations under the terms of our debt agreements and should not be used for assessing compliance or non-compliance with financial covenants under our debt agreements.

Because of these and other limitations, EBITDA and Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business.

Our presentation of non-GAAP financial measures and the adjustments made therein should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items, and in the future we may incur expenses or charges similar to the adjustments made in the presentation of our non-GAAP financial measures.

We compensate for these limitations by relying primarily on our GAAP results and using Adjusted Gross Profit, EBITDA, Adjusted EBITDA, and Adjusted Diluted Earnings Per Share only as supplemental measures. See our financial statements included elsewhere in this Form 10-Q.

We reconcile Gross Profit to Adjusted Gross Profit as follows:



	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
	(In thousands)						(In thousands)
Gross profit	$	67,810		$	63,824		$	161,807		$	192,977
Add (deduct):
Restructuring and other charges (a)	61			—			142			558
Production downtime (b)	(146		)	(990		)	(474		)	11,423
Non-cash compensation expense	122			136			396			508
Spread between FIFO and ECRC	926			1,816			40,144			(6,508		)
Adjusted gross profit	$	68,773		$	64,786		$	202,015		$	198,958

____________________________________________________


(a)	Severance expenses and other restructuring related charges.


(b)	In 2015 and the three months ended September 30, 2014, the reduction in costs is due to insurance recoveries related to the Belpre production downtime. In the nine months ended September 30, 2014, production downtime at our Belpre, Ohio and Berre, France facilities.

We reconcile consolidated net loss to EBITDA and Adjusted EBITDA as follows:



	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
	(In thousands)						(In thousands)
Net income (loss) attributable to Kraton	$	8,446		$	16,615		$	(6,574	)	$	19,849
Net loss attributable to noncontrolling interest	(427		)	(298		)	(1,141		)	(858		)
Consolidated net income (loss)	8,019			16,317			(7,715		)	18,991
Add:
Interest expense, net	6,151			6,099			17,975			18,667
Income tax expense	3,076			1,122			4,135			3,405
Depreciation and amortization	16,145			16,552			46,852			49,630
EBITDA	33,391			40,090			61,247			90,693
Add (deduct):
Restructuring and other charges (a)	533			—			1,499			653
Transaction and acquisition related costs (b)	4,968			(4,221		)	5,798			8,822
Production downtime (c)	(134		)	(990		)	(343		)	12,023
KFPC startup costs (d)	677			448			1,827			1,340
Non-cash compensation expense (e)	2,032			2,274			6,601			8,468
Spread between FIFO and ECRC	926			1,816			40,144			(6,508		)
Adjusted EBITDA	$	42,393		$	39,417		$	116,773		$	115,491

_____________________________________________________


(a)	Severance expenses, professional fees and other restructuring related charges which are primarily recorded in selling, general and administrative expenses in 2015 and primarily recorded in cost of goods sold in 2014.


(b)	Charges related to the evaluation of acquisition transactions which are recorded in selling, general and administrative expenses. In 2015, charges are primarily related to the proposed acquisition of Arizona Chemical, and in 2014, charges are primarily related to the terminated Combination Agreement with LCY.

(c)

In 2015 and the three months ended September 30, 2014, the reduction in costs is due to insurance recoveries related to the Belpre production downtime, which are primarily recorded in cost of goods sold. In the nine months ended September 30, 2014, production downtime at our Belpre, Ohio and Berre, France facilities, of which, $11.4 million is recorded in cost of goods sold and $0.6 million is recorded in selling, general and administrative expenses.


(d)	Startup costs related to the joint venture company, KFPC, which are recorded in selling, general and administrative expenses.

(e)

For the three months ended September 30, 2015 and 2014, respectively, $1.7 million and $2.0 million is recorded in selling, general and administrative expenses, $0.2 million and $0.2 million is recorded in research and development expenses, and $0.1 million and $0.1 million is recorded in cost of goods sold. For the nine months ended September 30, 2015 and 2014, respectively, $5.7 million and $7.3 million is recorded in selling, general and administrative expenses, $0.5 million and $0.7 million is recorded in research and development expenses, and $0.4 million and $0.5 million is recorded in cost of goods sold.

We reconcile GAAP Loss Per Diluted Share to Adjusted Earnings Per Diluted Share as follows:



	Three months ended September 30,						Nine months ended September 30,
	2015			2014			2015			2014
	(In thousands)						(In thousands)
GAAP Earnings (Loss) Per Diluted Share	$	0.27		$	0.50		$	(0.21	)	$	0.60
Restructuring and other charges (a)	0.02			—			0.05			0.02
Transaction and acquisition related costs (b)	0.16			(0.13		)	0.18			0.27
Production downtime (c)	(0.01		)	(0.03		)	(0.01		)	0.36
KFPC startup costs (d)	0.01			0.01			0.02			0.02
Valuation Allowance (e)	—			(0.06		)	—			(0.06		)
Spread between FIFO and ECRC	0.03			0.06			1.23			(0.19		)
Adjusted Earnings Per Diluted Share	$	0.48		$	0.35		$	1.26		$	1.01

_____________________________________________________


(a)	Severance expenses, professional fees and other restructuring related charges which are primarily recorded in selling, general and administrative expenses in 2015 and primarily recorded in cost of goods sold in 2014.


(b)	Charges related to the evaluation of acquisition transactions which are recorded in selling, general and administrative expenses. In 2015, charges are primarily related to the proposed acquisition of Arizona Chemical, and in 2014, charges are primarily related to the terminated Combination Agreement with LCY.

(c)

In 2015 and the three months ended September 30, 2014, the reduction in costs is due to insurance recoveries related to the Belpre production downtime, which are primarily recorded in cost of goods sold. In 2014, production downtime at our Belpre, Ohio and Berre, France facilities, of which, $11.4 million is recorded in cost of goods sold and $0.6 million is recorded in selling, general and administrative expenses.


(d)	Startup costs related to the joint venture company, KFPC, which are recorded in selling, general and administrative expenses.


(e)	Reduction of income tax valuation allowance related to the assessment of our ability to utilize net operating losses in future periods.

LIQUIDITY AND CAPITAL RESOURCES

Description of Senior Secured Credit Facilities

In March 2013, we entered into an asset-based revolving credit facility consisting of a U.S. senior secured revolving credit facility of $150.0 million and a Dutch senior secured revolving credit facility of $100.0 million (the “Senior Secured Credit Facilities”), to replace our then-existing senior secured credit facility, and repaid in full all outstanding amounts payable under the previously existing facility.

The Senior Secured Credit Facilities are principally secured by receivables and inventory, and borrowing availability under the facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security. The Senior Secured Credit Facilities include a $100.0 million uncommitted accordion feature that, subject to borrowing base availability and approval of the bank syndicate, could increase aggregate availability to $350.0 million. We cannot guarantee that all of the lending counterparties contractually committed to fund a revolving credit draw request will actually fund future requests, although we currently believe that each of the counterparties would meet their funding requirements. The Senior Secured Credit Facilities terminate on March 27, 2018; however, we may, from time to time, request that the lenders extend the maturity of their commitments provided that at no time shall there be more than four maturity dates under the Senior Secured Credit Facilities.

The Senior Secured Credit Facilities contain a financial covenant requiring us to maintain a fixed charge coverage ratio of 1.0 to 1.0 if availability under the facilities is below specified amounts. Our failure to comply with this financial maintenance covenant would give rise to a default under the Senior Secured Credit Facilities. If factors arise that negatively impact our profitability, we may not be able to satisfy this covenant. In addition, the Senior Secured Credit Facilities contain customary events of default, including, without limitation, a failure to make payments under the facilities, cross-default with respect to other indebtedness and cross-judgment default, certain bankruptcy events and certain change of control events. If we are unable to satisfy the covenants or other provisions of the Senior Secured Credit Facilities at any future time, we would need to seek an amendment or waiver of such covenants or other provisions. The respective lenders under the Senior Secured Credit Facilities may elect not to consent to any amendment or waiver requests that we may make in the future, and, if they do consent, they may do so on terms that are not favorable to us. In the event that we are unable to obtain any such waiver or amendment and we are not able to refinance or repay our Senior Secured Credit Facilities, our inability to meet the covenants or other provisions of the Senior Secured Credit Facilities would constitute an event of default, which would permit the bank lenders to accelerate the Senior Secured Credit Facilities. Such acceleration may in turn constitute an event of default under our senior notes or other indebtedness. At September 30, 2015, we were in compliance with the covenants under the Senior Secured Credit Facilities. For additional information regarding our Senior Secured Credit Facilities, see “Senior Secured Credit Facilities” in Note 7 Long-Term Debt, which is incorporated herein by reference.

Description of 6.75% Senior Notes due 2019

Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019. The notes are general unsecured, senior obligations and are unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year. After March 1, 2015, 2016, and 2017 and thereafter, we may redeem all or a part of the senior notes for 103.375%, 101.688%, and 100.000%, of the principal amount, respectively. At September 30, 2015, we were in compliance with the covenants under the indenture governing our 6.75% senior notes. For additional information regarding our 6.75% senior notes, see “6.75% Senior Notes due 2019” in Note 7 Long-Term Debt, which is incorporated herein by reference.

Description of KFPC Loan Agreement

On July 17, 2014, KFPC executed a syndicated loan agreement (the “KFPC Loan Agreement”) in the amount of 5.5 billion New Taiwanese Dollars (“NTD”), or $166.3 million (converted at the September 30, 2015 exchange rate), to provide additional funding to construct the HSBC facility in Taiwan and to provide funding for working capital requirements and/or general corporate purposes.

The KFPC Loan Agreement is comprised of a NTD 4.29 billion Tranche A, or $129.7 million (converted at the September 30, 2015 exchange rate), to fund KFPC’s capital expenditures, and a NTD 1.21 billion Tranche B, or $36.6 million (converted at the September 30, 2015 exchange rate), to fund working capital requirements and/or general corporate purposes. As of September 30, 2015, NTD 1.7 billion, or $52.6 million (converted at the September 30, 2015 exchange rate) was drawn on the KFPC Loan Agreement. The facility period of the KFPC Loan Agreement is five years from January 17, 2015 (the first drawdown date). KFPC may continue to draw on the loan agreement for the first 28 months following the first drawdown date. Subject to certain conditions, KFPC can request a two-year extension of the facility period of the KFPC Loan Agreement.

The KFPC Loan Agreement contains certain financial covenants which change during the term of the KFPC Loan Agreement. The financial covenants include a maximum debt to equity ratio of 3.0 to 1.0 through 2016, which will decrease to 2.0 to 1.0 in 2017 and 1.2 to 1.0 in 2018; a minimum tangible net worth requirement of $50.0 million through 2018, which will increase to $100.0 million in 2019; and a minimum interest coverage ratio of 2.5 to 1.0 commencing in 2016, which will increase to 5.0 to 1.0 in 2017. In each case, these covenants are calculated and tested on an annual basis. Formosa Petrochemical Corporation and Kraton Polymers LLC are the guarantors of the KFPC Loan Agreement with each guarantor guaranteeing 50% of the indebtedness. At September 30, 2015, KFPC was in compliance with the covenants under the KFPC Loan Agreement. For additional information regarding our KFPC Loan Agreement, see “KFPC Loan Agreement” in Note 7 Long-Term Debt, which is incorporated herein by reference.

Known Trends and Uncertainties

On September 27, 2015, Kraton Polymers LLC, one of our wholly owned subsidiaries, entered into a definitive agreement to acquire all of the capital stock of Arizona Chemical for a cash purchase price of $1,370.0 million, subject to adjustment for cash and indebtedness at closing, as well as an adjustment for working capital and other items. The Arizona Chemical Acquisition is expected to close in late 2015 or early 2016, subject to certain customary closing conditions and the clearances and approvals under the rules of antitrust and competition law authorities in the United States, Germany, Russia and the Ukraine. We anticipate funding the Arizona Chemical Acquisition with a combination of borrowings under new senior secured credit facilities and an offering of debt securities. In connection with the pending acquisition, we secured commitment letters to fund the purchase price.

Kraton Performance Polymers, Inc. is a holding company without any operations or assets other than the operations of its subsidiaries. Cash flows from operations of our subsidiaries, cash on hand and available borrowings under our Senior Secured Credit Facilities are our principal sources of liquidity.

Based upon current and anticipated levels of operations, we believe that cash flows from operations of our subsidiaries, cash on hand, and borrowings available to us will be sufficient to fund our expected financial obligations, planned capital expenditures and anticipated liquidity requirements, including working capital requirements, our investment in the KFPC joint venture, debt payments, interest payments, benefit plan contributions and income tax obligations. In addition, we believe that we will be able to obtain borrowings on terms favorable to us that will be sufficient to fund the purchase price of the Arizona Chemical Acquisition.

Our cash flows are subject to a number of risks and uncertainties, including, but not limited to, earnings, sensitivities to the cost of raw materials, seasonality and fluctuations in foreign currency exchange rates, and accessibility or availability of adequate financing to fund the pending Arizona Chemical Acquisition. Because feedstock costs generally represent a substantial portion of our cost of goods sold, in periods of rising feedstock costs, we generally consume cash in operating activities due to increases in accounts receivable and inventory costs, partially offset by increased value of accounts payable. Conversely, during periods in which feedstock costs are declining, we generate cash flow from decreases in working capital.

Going forward there can be no assurance that our business will generate sufficient cash flow from operations or that future borrowings will be available under the Senior Secured Credit Facilities or any new credit facilities and financing arrangements to fund liquidity needs and enable us to service our indebtedness. At September 30, 2015, we had $63.8 million of cash and cash equivalents, which includes $11.0 million of cash-on-hand at KFPC, the consolidated joint venture in Asia. As of September 30, 2015, our available borrowing capacity under the Senior Secured Credit Facilities was $169.6 million of which none was drawn and as of October 26, 2015, our available borrowing capacity was $167.8 million, of which none was drawn. Excluding the $11.0 million of KFPC cash, our liquidity at September 30, 2015 amounted to $222.4 million. Our available cash and cash equivalents are held in accounts managed by third-party financial institutions and consist of cash invested in interest bearing funds and operating accounts. To date, we have not experienced any losses or lack of access to our invested cash or cash equivalents; however, we cannot provide any assurance that adverse conditions in the financial markets will not impact access to our invested cash and cash equivalents.

We made contributions of $1.1 million to our pension plan in the nine months ended September 30, 2015 and $7.2 million in the nine months ended September 30, 2014. We expect our total pension plan contributions for the year ending December 31, 2015 to be $1.8 million. Our pension plan obligations are predicated on a number of factors, the primary ones being the return on our pension plan assets and the discount rate used in deriving our pension obligations. If the investment return on our pension plan assets does not meet or exceed expectations during 2015, and the discount rate decreases from the prior year, higher levels of contributions could be required in 2016 and beyond.

As of September 30, 2015, we had $62.5 million of cash and short-term investments related to foreign operations that management asserts are permanently reinvested. As a result of net operating loss carryforwards, management estimates that approximately $1.3 million of additional cash tax expense would be incurred if this cash were repatriated.

Turbulence in U.S. and international markets and economies may adversely affect our liquidity and financial condition, the liquidity and financial condition of our customers, and our ability to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in adverse effects on our financial condition and results of operations. However, to date we have been able to access borrowings available to us in amounts sufficient to fund liquidity needs.

Our ability to pay principal and interest on our indebtedness, fund working capital, make anticipated capital expenditures and fund our investment in the KFPC joint venture depends on our future performance, which is subject to general economic conditions and other factors, some of which are beyond our control. “See Part I, Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2014 for further discussion.

Operating Cash Flows

Net cash provided by operating activities totaled $81.6 million in the nine months ended September 30, 2015 compared to $18.8 million of net cash used in operating activities in the nine months ended September 30, 2014. This represents a net increase in operating cash flows of $100.4 million, which was primarily driven by changes in working capital. The net change in working capital provided cash flows of $36.5 million for the nine months ended September 30, 2015 compared to a use of cash of $94.3 million for the nine months ended September 30, 2014, a period-over-period increase in operating cash flows of $130.9 million. The period-over-period changes are as follows:

•

$79.3 million increase in cash flows associated with inventories of products, materials and supplies, due to a decrease in inventory volumes for the nine months ended September 30, 2015 compared to an increase in inventory volumes for the nine months ended September 30, 2014. In addition, cash flows associated with inventories increased as a result of declining costs of raw material and finished goods inventories for the nine months ended September 30, 2015;


•	$27.0 million increase in cash flows associated with trade accounts payable due to the timing of payments; and a


•	$24.6 million net increase in cash flows due to the timing of payments of other items, including accounts receivable, related party transactions, taxes, and pension costs.

Investing Cash Flows

Net cash used in investing activities totaled $90.2 million for the nine months ended September 30, 2015 and $84.1 million for the nine months ended September 30, 2014, which includes $46.1 million and $33.8 million, respectively, related to capital expenditures incurred by KFPC, our 50/50 joint venture with FPCC.

Expected Capital Expenditures

We currently expect 2015 capital expenditures, excluding capital expenditures by the KFPC joint venture and capitalized interest, will be approximately $55.0 million to $60.0 million. Included in this estimate is approximately $9.2 million to comply with the boiler MACT regulations and approximately $20.0 million to $23.0 million for health, safety and environmental and infrastructure and maintenance projects. The remaining anticipated 2015 capital expenditures are primarily associated with projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform.

We currently anticipate the total KFPC joint venture project construction cost will be approximately $200.0 million to $210.0 million; of which, 2015 capital expenditures will be approximately $75.0 million to $80.0 million. The project has been funded with a combination of equity and debt financing. From the inception of the project to September 30, 2015, we and FPCC have each made equity investments of $41.6 million to KFPC. On July 17, 2014, KFPC executed a syndicated loan agreement in the amount of 5.5 billion NTD, or $166.3 million (converted at the September 30, 2015 exchange rate), to provide the debt portion of the project financing including funding for working capital and/or general corporate purposes. Kraton Polymers LLC and FPCC are guarantors of the KFPC Loan Agreement with each guaranteeing 50% of the indebtedness. See Note 7 Long-Term Debt, for further discussion of the KFPC Loan Agreement.

Financing Cash Flows

Our consolidated capital structure as of September 30, 2015 was approximately 45.1% equity, 50.5% debt and 4.4% noncontrolling interest compared to approximately 52.5% equity, 42.9% debt, and 4.6% noncontrolling interest at December 31, 2014.

Net cash provided by financing activities totaled $24.7 million for the nine months ended September 30, 2015 compared to net cash used in financing activities of $5.8 million for the nine months ended September 30, 2014. In the nine months ended September 30, 2015, the KFPC joint venture drew $55.6 million on the KFPC Loan Agreement for construction funding partially offset by cash outflows of $31.3 million (excluding trading commissions) for repurchases of shares of our common stock as part of our share repurchase program approved in October 2014.

Contractual Commitments

Our contractual obligations are summarized in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our annual report on Form 10-K for the year ended December 31, 2014. Other than our obligations under the Arizona Chemical Acquisition stock purchase agreement, there have been no material changes to the contractual obligation amounts disclosed in our annual report on Form 10-K for the year ended December 31, 2014.

Off-Balance Sheet Arrangements

We are not involved in any material off-balance sheet arrangements as of September 30, 2015, other than operating leases.


Item 3.	Quantitative and Qualitative Disclosures about Market Risk.

For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our annual report on Form 10-K for the year ended December 31, 2014. There have been no material changes to the quantitative and qualitative disclosures about market risk disclosed in our annual report on Form 10-K for the year ended December 31, 2014. See Note 9 Fair Value Measurements, Financial Instruments and Credit Risk for further discussion.


Item 4.	Controls and Procedures.

An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934) was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. As of September 30, 2015, based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective.

There has been no change in our internal control over financial reporting that occurred during the three months ended September 30, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION


Item 1.	Legal Proceedings.

We are subject to a number of contingencies, including litigation, from time to time. On October 6, 2014, we and two of our subsidiaries, Kraton Performance Polymers Limited and NY MergerCo, LLC, were named as defendants in a lawsuit filed by LCY Chemical Corp. and its subsidiary, LCY Synthetic Rubber Corp. (together, the “LCY Parties”), in connection with the previously announced termination of the Combination Agreement. The lawsuit alleges breach of contract by Kraton and seeks payment of a $25.0 million termination fee, along with awards of unspecified compensatory, expectancy and consequential damages. The lawsuit was filed in the United States District Court for the District of Delaware. On July 23, 2015, LCY's lawsuit was dismissed from the Delaware federal court on jurisdictional grounds. LCY has the right to re-file its suit in Delaware state court. As of the date of this filing, they had not re-filed their suit. While the ultimate resolution of this lawsuit cannot be predicted with certainty, we do not expect any material adverse effect upon our financial position, results of operations or cash flows from the ultimate outcome of this lawsuit.

In January 2014, our Belpre, Ohio, facility experienced a mechanical equipment failure due to inclement weather that resulted in a release of process solvents into nearby waterways. Applicable authorities were notified, and cleanup activities have been completed. Kraton may be required to pay governmental fines or sanctions in excess of $100,000 in connection with this event.

For further information regarding legal proceedings, see Note 11 Commitments and Contingencies, to our condensed consolidated financial statements.


Item 1A.	Risk Factors.

Readers of this Quarterly Report on Form 10-Q should carefully consider the risks described in our other reports and filings filed with or furnished to the SEC, including our prior and subsequent reports on Forms 10-K, 10-Q and 8-K, in connection with any evaluation of our financial position, results of operations and cash flows.

The risks and uncertainties in our most recent Annual Report on Form 10-K, are not the only risks that we face. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect our operations. Any of the risks, uncertainties, events or circumstances described therein could cause our future financial condition, results of operations or cash flows to be adversely affected.

There have been no material changes from the risk factors disclosed in our most recent Annual Report on Form 10-K, except as described below.

Closing of the Arizona Chemical Acquisition is subject to a number of regulatory conditions. The Arizona Chemical Acquisition is subject to review by the Antitrust Division of the Department of Justice and the Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and by the antitrust and competition authorities in Germany, Russia and the Ukraine, and potentially other jurisdictions. Conditions to closing the Arizona Chemical Acquisition include the clearance and approval under the rules of the antitrust and competition authorities and that there is no judgment or regulatory action of a governmental body in effect that prohibits the Arizona Chemical Acquisition contemplated by the Acquisition Agreement. We can provide no assurance that all required regulatory clearances will be obtained or that the conditions associated with such clearances will be acceptable to either party. In addition, in some circumstances, a third party could initiate a private action under applicable antitrust and competition laws challenging or seeking to enjoin the Arizona Chemical Acquisition, before or after it is completed. We may not prevail and may incur significant costs in defending or settling any action under the antitrust and competition laws.

Failure to complete the Arizona Chemical Acquisition, or significant delays in completing the Arizona Chemical Acquisition, could negatively affect our future business and financial results. If the Arizona Chemical Acquisition is not completed, or if there are significant delays in completing the Arizona Chemical Acquisition, our future business and financial results could be negatively affected, and we will be subject to several risks, including the following:


•	the parties may be liable for damages to one another under the terms and conditions of the Acquisition Agreement;


•	negative reactions from the financial markets;


•	having to pay certain significant costs relating to the Arizona Chemical Acquisition; and


•	the attention of our management will have been diverted to the Arizona Chemical Acquisition rather than to our current operations and pursuit of other opportunities that could have been beneficial the the Company.

We may have difficulties integrating the operations of Arizona Chemical. If we are unable to integrate or to successfully manage the Arizona Chemical operations, our business, financial condition, results of operations and cash flows could be adversely affected. We may not be able to realize the operating efficiencies, synergies, cost savings or other benefits expected from the pending Arizona Chemical Acquisition for a number of reasons, including, but not limited to, the following: (i) we may fail to integrate the Arizona Chemical business with our existing business into a cohesive, efficient enterprise; (ii) our resources, including management resources, are limited and may be strained, and the Arizona Chemical Acquisition may divert our management's attention from initiating or carrying out programs to save costs or enhance revenues; (iii) our failure to retain key employees and contracts of Arizona Chemical; and (iv) we may fail to identify operating problems or liabilities prior to closing of the Arizona Chemical Acquisition.


Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.

Following is a summary of our repurchases of common stock during the three months ended September 30, 2015.



Period	Total Number of Shares Purchased (a)	Average Price Paid Per Share	Total Number of Shares Purchased as Part of a Publicly Announced Program (a)	Maximum Dollar Value (in millions) of Shares that May Yet Be Purchased Under the Program (a)
August 1 - 31, 2015	453,224	$20.59	453,224	$7.9
September 1 - 30, 2015	373,918	$20.98	373,918	$0.0
Total	827,142	$20.77	827,142	$0.0

No shares were repurchased in the month of July 2015.

(a)

On October 27, 2014, our board of directors approved a share repurchase plan which allowed for the repurchase of outstanding shares of our common stock having an aggregate purchase price of up to $50.0 million. During the three months ended September 30, 2015, we repurchased 827,142 shares of our common stock at an average price of $20.77 per share and a total cost of $17.2 million (including trading commissions). From the inception of the program through September 30, 2015, we repurchased a total of 2,549,683 shares of our common stock at an average price of $19.58 per share and a total cost of $50.0 million (including trading commissions). The share repurchase program was financed with available cash and the program is now complete.


Item 6.	Exhibits.



Exhibit Number
2.1		Stock Purchase Agreement, dated as of September 27, 2015, by and among AZC Holding Company LLC, Arizona Chemicals Holdings Corporation and Kraton Polymers LLC (incorporated by reference to Exhibit 2.1 to Kraton Performance Polymers, Inc.'s Current Report on Form 8-K filed with the SEC on September 30, 2015).
31.1*		Certification of Chief Executive Officer under Section 302 of Sarbanes—Oxley Act of 2002
31.2*		Certification of Chief Financial Officer under Section 302 of Sarbanes—Oxley Act of 2002
32.1*		Certification Pursuant to Section 906 of Sarbanes—Oxley Act of 2002
101*		The following materials from Kraton Performance Polymers, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014 (Unaudited), (ii) Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2015 and 2014 (Unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2015 and 2014 (Unaudited), (iv) Condensed Consolidated Statements of Changes in Equity for the nine months ended September 30, 2015 and 2014 (Unaudited), (v) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2015 and 2014 (Unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (Unaudited).

_________________________________________________


*	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



		KRATON PERFORMANCE POLYMERS, INC.

Date:	October 29, 2015	/s/ Kevin M. Fogarty
		Kevin M. Fogarty
		President and Chief Executive Officer

Date:	October 29, 2015	/s/ Stephen E. Tremblay
		Stephen E. Tremblay
		Executive Vice President and Chief Financial Officer